| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-20 | 2009-09-30 | 13F-HR | California State Teachers Retirement System | Institution | 182,235 | Sold Some | -25 | -0.01 % | $3,830,580 | $3,830,580 | $0 | 0.00 % | $0 | | | | | | News Article | History of California State Teachers Retirement System Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-20 | 2009-09-30 | 13F-HR/A | Ing Investment Management Europe B V | Institution | 36,100 | Sold Some | -5,000 | -12.16 % | $758,822 | $758,822 | $0 | 0.00 % | $0 | | | | | | News Article | History of Ing Investment Management Europe B V Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-20 | 2009-09-30 | 13F-HR/A | Janus Capital Management Llc | Institution | | Sold All | -104,000 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Janus Capital Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-20 | 2009-09-30 | 13F-HR | Whitney National Bank | Institution | | Sold All | -46,503 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Whitney National Bank Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Royal Bank Of Canada Trust Co Ltd | Institution | 50 | No Change | 0 | 0 % | $1,052 | $1,051 | $-1 | -0.09 % | $0 | | | | | | News Article | History of Royal Bank Of Canada Trust Co Ltd Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 4,983,029 | Added More | 328,929 | 7.06 % | $105,690,045 | $104,743,270 | $-946,776 | -0.89 % | $-62,497 | | | | | | News Article | History of Amvescap Plc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 139,310 | Added More | 54,455 | 64.17 % | $2,954,765 | $2,928,296 | $-26,469 | -0.89 % | $-10,346 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Rothschild Asset Management Inc | Institution | | Sold All | -99,990 | -100 % | | | | -0.89 % | $18,998 | | | | | | News Article | History of Rothschild Asset Management Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 681,757 | Added More | 148,114 | 27.75 % | $14,460,066 | $14,330,532 | $-129,534 | -0.89 % | $-28,142 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Acadia Trust Na | Institution | | Sold All | -490 | -100 % | | | | -0.80 % | $83 | | | | | | News Article | History of Acadia Trust Na Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Alyeska Investment Group Lp | No Data | 250,000 | New Holding | 250,000 | 100 % | $5,297,500 | $5,255,000 | $-42,500 | -0.80 % | $-42,500 | | | | | | News Article | History of Alyeska Investment Group Lp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 273,695 | Sold Some | -31,262 | -10.25 % | $5,799,597 | $5,753,069 | $-46,528 | -0.80 % | $5,315 | | | | | | News Article | History of American International Group Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Aqr Capital Management Llc | Institution | 1,355,164 | Added More | 114,157 | 9.19 % | $28,715,925 | $28,485,547 | $-230,378 | -0.80 % | $-19,407 | | | | | | News Article | History of Aqr Capital Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Argus Management Llc | Institution | 90,000 | Added More | 15,000 | 20.00 % | $1,907,100 | $1,891,800 | $-15,300 | -0.80 % | $-2,550 | | | | | | News Article | History of Argus Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Balyasny Asset Management Llc | Institution | 194,800 | New Holding | 194,800 | 100 % | $4,127,812 | $4,094,696 | $-33,116 | -0.80 % | $-33,116 | | | | | | News Article | History of Balyasny Asset Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Breeden Capital Management Llc | Institution | 585,377 | New Holding | 585,377 | 100 % | $12,404,139 | $12,304,625 | $-99,514 | -0.80 % | $-99,514 | | | | | | News Article | History of Breeden Capital Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cadian Capital Management Llc | Institution | | Sold All | -244,647 | -100 % | | | | -0.80 % | $41,590 | | | | | | News Article | History of Cadian Capital Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Capital World Investors | Institution | 7,401,150 | Sold Some | -600,000 | -7.49 % | $156,830,369 | $155,572,173 | $-1,258,196 | -0.80 % | $102,000 | | | | | | News Article | History of Capital World Investors Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 136,077 | Added More | 25,756 | 23.34 % | $2,883,472 | $2,860,339 | $-23,133 | -0.80 % | $-4,379 | | | | | | News Article | History of Citadel L P Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Concert Wealth Management Inc | No Data | 1,000 | New Holding | 1,000 | 100 % | $21,190 | $21,020 | $-170 | -0.80 % | $-170 | | | | | | News Article | History of Concert Wealth Management Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Croft Leominster Inc | Institution | 177,553 | Added More | 1,171 | 0.66 % | $3,762,348 | $3,732,164 | $-30,184 | -0.80 % | $-199 | | | | | | News Article | History of Croft Leominster Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Dsm Capital Partners Llc | Institution | 1,856,471 | New Holding | 1,856,471 | 100 % | $39,338,620 | $39,023,020 | $-315,600 | -0.80 % | $-315,600 | | | | | | News Article | History of Dsm Capital Partners Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Eaton Vance Management | Institution | 26,304 | Sold Some | -51 | -0.19 % | $557,382 | $552,910 | $-4,472 | -0.80 % | $9 | | | | | | News Article | History of Eaton Vance Management Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Eaton Vance Management | Institution | 26,304 | Sold Some | -785 | -2.89 % | $557,382 | $552,910 | $-4,472 | -0.80 % | $133 | | | | | | News Article | History of Eaton Vance Management Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Employees Retirement System Of Texas | Institution | 146,600 | Added More | 119,000 | 431.15 % | $3,106,454 | $3,081,532 | $-24,922 | -0.80 % | $-20,230 | | | | | | News Article | History of Employees Retirement System Of Texas Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fifth Third Asset Management Inc | Institution | 36,850 | Sold Some | -7,124 | -16.20 % | $780,852 | $774,587 | $-6,265 | -0.80 % | $1,211 | | | | | | News Article | History of Fifth Third Asset Management Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fifth Third Bancorp | Institution | 33,427 | Sold Some | -1,217 | -3.51 % | $708,318 | $702,636 | $-5,683 | -0.80 % | $207 | | | | | | News Article | History of Fifth Third Bancorp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 492,640 | Sold Some | -551,544 | -52.82 % | $10,439,042 | $10,355,293 | $-83,749 | -0.80 % | $93,762 | | | | | | News Article | History of Fmr Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Furgueson Capital Management | Institution | 13,990 | Sold Some | -400 | -2.77 % | $296,448 | $294,070 | $-2,378 | -0.80 % | $68 | | | | | | News Article | History of Furgueson Capital Management Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 247,817 | Sold Some | -13,450 | -5.14 % | $5,251,242 | $5,209,113 | $-42,129 | -0.80 % | $2,287 | | | | | | News Article | History of Ing Groep Nv Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Mackenzie Financial Corp | Institution | 16,500 | New Holding | 16,500 | 100 % | $349,635 | $346,830 | $-2,805 | -0.80 % | $-2,805 | | | | | | News Article | History of Mackenzie Financial Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Madison Square Investors Llc | No Data | 194,248 | Sold Some | -20,972 | -9.74 % | $4,116,115 | $4,083,093 | $-33,022 | -0.80 % | $3,565 | | | | | | News Article | History of Madison Square Investors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Madison Street Partners Llc | Institution | 25,355 | Added More | 13,405 | 112.17 % | $537,272 | $532,962 | $-4,310 | -0.80 % | $-2,279 | | | | | | News Article | History of Madison Street Partners Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 222,975 | Sold Some | -21,332 | -8.73 % | $4,724,840 | $4,686,935 | $-37,906 | -0.80 % | $3,626 | | | | | | News Article | History of Millennium Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 1,933,874 | Added More | 452,882 | 30.57 % | $40,978,790 | $40,650,031 | $-328,759 | -0.80 % | $-76,990 | | | | | | News Article | History of Morgan Stanley Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | New York State Teachers Retirement System | Institution | 199,714 | New Holding | 199,714 | 100 % | $4,231,940 | $4,197,988 | $-33,951 | -0.80 % | $-33,951 | | | | | | News Article | History of New York State Teachers Retirement System Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Co Of Connecticut | Institution | | Sold All | -75,600 | -100 % | | | | -0.80 % | $12,852 | | | | | | News Article | History of Northern Trust Co Of Connecticut Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 920,697 | Sold Some | -24,562 | -2.59 % | $19,509,569 | $19,353,051 | $-156,518 | -0.80 % | $4,176 | | | | | | News Article | History of Northern Trust Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Nyl Trust Co | Institution | 13,050 | Sold Some | -1,622 | -11.05 % | $276,530 | $274,311 | $-2,219 | -0.80 % | $276 | | | | | | News Article | History of Nyl Trust Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | | Sold All | -7,030 | -100 % | | | | -0.80 % | $1,195 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Perimeter Capital Partners Llc | Institution | | Sold All | -13,802 | -100 % | | | | -0.80 % | $2,346 | | | | | | News Article | History of Perimeter Capital Partners Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Philadelphia Trust Co | Institution | 253,955 | Added More | 172,955 | 213.52 % | $5,381,306 | $5,338,134 | $-43,172 | -0.80 % | $-29,402 | | | | | | News Article | History of Philadelphia Trust Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Rafferty Asset Management Llc | Institution | 10,530 | Sold Some | -1,902 | -15.29 % | $223,131 | $221,341 | $-1,790 | -0.80 % | $323 | | | | | | News Article | History of Rafferty Asset Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sac Capital Advisors Lp | No Data | 19,146 | New Holding | 19,146 | 100 % | $405,704 | $402,449 | $-3,255 | -0.80 % | $-3,255 | | | | | | News Article | History of Sac Capital Advisors Lp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | | Sold All | -15,804 | -100 % | | | | -0.80 % | $2,687 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | State Treasurer State Of Michigan | Institution | 74,800 | Sold Some | -1,100 | -1.44 % | $1,585,012 | $1,572,296 | $-12,716 | -0.80 % | $187 | | | | | | News Article | History of State Treasurer State Of Michigan Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Straus Capital Management Llc | Institution | 138,300 | Added More | 3,300 | 2.44 % | $2,930,577 | $2,907,066 | $-23,511 | -0.80 % | $-561 | | | | | | News Article | History of Straus Capital Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | 117,551 | Sold Some | -52,800 | -30.99 % | $2,490,906 | $2,470,922 | $-19,984 | -0.80 % | $8,976 | | | | | | News Article | History of Ubs Global Asset Management Americas Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 15,433 | Sold Some | -4,507 | -22.60 % | $327,025 | $324,402 | $-2,624 | -0.80 % | $766 | | | | | | News Article | History of Us Bancorp De Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Visium Asset Management Llc | Institution | | Sold All | -18,900 | -100 % | | | | -0.80 % | $3,213 | | | | | | News Article | History of Visium Asset Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wasatch Advisors Inc | Institution | 1,228,650 | Added More | 260,345 | 26.88 % | $26,035,094 | $25,826,223 | $-208,871 | -0.80 % | $-44,259 | | | | | | News Article | History of Wasatch Advisors Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | | Sold All | -1,434,727 | -100 % | | | | -0.80 % | $243,904 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-11-13 | 13F-HR | Wilmington Trust Fsb | Institution | 9,250 | New Holding | 9,250 | 100 % | $191,105 | $194,435 | $3,330 | 1.74 % | $3,330 | | | | | | News Article | History of Wilmington Trust Fsb Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-10-31 | 13F-HR | Peak6 Investments L P | Institution | 4,222 | Sold Some | -32,078 | -88.36 % | $87,227 | $88,746 | $1,520 | 1.74 % | $-11,548 | | | | | | News Article | History of Peak6 Investments L P Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 451,254 | Sold Some | -187,695 | -29.37 % | $9,322,908 | $9,485,359 | $162,451 | 1.74 % | $-67,570 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Aston Asset Management Llc | Institution | 384,962 | Sold Some | -146,900 | -27.61 % | $7,953,315 | $8,091,901 | $138,586 | 1.74 % | $-52,884 | | | | | | News Article | History of Aston Asset Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Aston Asset Management Llc | Institution | 384,962 | Added More | 372,612 | 3017.10 % | $7,953,315 | $8,091,901 | $138,586 | 1.74 % | $134,140 | | | | | | News Article | History of Aston Asset Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Atlanta Capital Management Co L L C | Institution | | Sold All | -330 | -100 % | | | | 1.74 % | $-119 | | | | | | News Article | History of Atlanta Capital Management Co L L C Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 153,270 | Sold Some | -634,053 | -80.53 % | $3,166,558 | $3,221,735 | $55,177 | 1.74 % | $-228,259 | | | | | | News Article | History of Axa Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bank Of Albuquerque Na | No Data | | Sold All | -9,920 | -100 % | | | | 1.74 % | $-3,571 | | | | | | News Article | History of Bank Of Albuquerque Na Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bank Of Oklahoma National Association | No Data | | Sold All | -32,518 | -100 % | | | | 1.74 % | $-11,706 | | | | | | News Article | History of Bank Of Oklahoma National Association Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 560,813 | Added More | 332,669 | 145.81 % | $11,586,397 | $11,788,289 | $201,893 | 1.74 % | $119,761 | | | | | | News Article | History of Barclays Plc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barrett Associates Inc Ny | Institution | 750 | Sold Some | -145,235 | -99.48 % | $15,495 | $15,765 | $270 | 1.74 % | $-52,285 | | | | | | News Article | History of Barrett Associates Inc Ny Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 80,818 | Added More | 10,352 | 14.69 % | $1,669,700 | $1,698,794 | $29,094 | 1.74 % | $3,727 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Asset Management S A S | Institution | 145,889 | New Holding | 145,889 | 100 % | $3,014,067 | $3,066,587 | $52,520 | 1.74 % | $52,520 | | | | | | News Article | History of Bnp Paribas Asset Management S A S Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Brandywine Asset Management Llc | Institution | 37,170 | New Holding | 37,170 | 100 % | $767,932 | $781,313 | $13,381 | 1.74 % | $13,381 | | | | | | News Article | History of Brandywine Asset Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Cambridge Trust Co | Institution | | Sold All | -9,038 | -100 % | | | | 1.74 % | $-3,254 | | | | | | News Article | History of Cambridge Trust Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Capital Fund Management S A | Institution | 1,552 | New Holding | 1,552 | 100 % | $32,064 | $32,623 | $559 | 1.74 % | $559 | | | | | | News Article | History of Capital Fund Management S A Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Clearbridge Advisors Llc | Institution | 457,373 | Sold Some | -3,507 | -0.76 % | $9,449,326 | $9,613,980 | $164,654 | 1.74 % | $-1,263 | | | | | | News Article | History of Clearbridge Advisors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | 7,728 | Sold Some | -111 | -1.41 % | $159,660 | $162,443 | $2,782 | 1.74 % | $-40 | | | | | | News Article | History of Credit Agricole S A Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Delaware Management Business Trust | Institution | 28,000 | Sold Some | -150,800 | -84.34 % | $578,480 | $588,560 | $10,080 | 1.74 % | $-54,288 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dnb Asset Management Us Inc | Institution | | Sold All | -21,999 | -100 % | | | | 1.74 % | $-7,920 | | | | | | News Article | History of Dnb Asset Management Us Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Earnest Partners Llc | Institution | 6,174,854 | Sold Some | -411,554 | -6.24 % | $127,572,484 | $129,795,431 | $2,222,947 | 1.74 % | $-148,159 | | | | | | News Article | History of Earnest Partners Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ensemble Capital Management Llc | Institution | 59,675 | Sold Some | -5,450 | -8.36 % | $1,232,886 | $1,254,369 | $21,483 | 1.74 % | $-1,962 | | | | | | News Article | History of Ensemble Capital Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Expo Capital Management Llc | Institution | 215,000 | New Holding | 215,000 | 100 % | $4,441,900 | $4,519,300 | $77,400 | 1.74 % | $77,400 | | | | | | News Article | History of Expo Capital Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | First Mercantile Trust Co | Institution | 20,400 | No Change | 0 | 0 % | $421,464 | $428,808 | $7,344 | 1.74 % | $0 | | | | | | News Article | History of First Mercantile Trust Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | First National Bank Of Omaha | Institution | 63,475 | Sold Some | -26,670 | -29.58 % | $1,311,394 | $1,334,245 | $22,851 | 1.74 % | $-9,601 | | | | | | News Article | History of First National Bank Of Omaha Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 5,217 | Sold Some | -244,783 | -97.91 % | $107,783 | $109,661 | $1,878 | 1.74 % | $-88,122 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 242,965 | Added More | 13,116 | 5.70 % | $5,019,657 | $5,107,124 | $87,467 | 1.74 % | $4,722 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 94,827 | Sold Some | -73,219 | -43.57 % | $1,959,126 | $1,993,264 | $34,138 | 1.74 % | $-26,359 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hambrecht And Quist Capital Management Llc | Institution | 334,940 | Added More | 52,000 | 18.37 % | $6,919,860 | $7,040,439 | $120,578 | 1.74 % | $18,720 | | | | | | News Article | History of Hambrecht And Quist Capital Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hbk Investments L P | Institution | 10,000 | New Holding | 10,000 | 100 % | $206,600 | $210,200 | $3,600 | 1.74 % | $3,600 | | | | | | News Article | History of Hbk Investments L P Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jh Whitney Investment Management Llc | Institution | 9,300 | Sold Some | -4,500 | -32.60 % | $192,138 | $195,486 | $3,348 | 1.74 % | $-1,620 | | | | | | News Article | History of Jh Whitney Investment Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Keybank National Association | Institution | 492,841 | Sold Some | -243,212 | -33.04 % | $10,182,095 | $10,359,518 | $177,423 | 1.74 % | $-87,556 | | | | | | News Article | History of Keybank National Association Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | | Sold All | -11,126 | -100 % | | | | 1.74 % | $-4,005 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Legg Mason Investment Counsel Llc | Institution | 6,300 | New Holding | 6,300 | 100 % | $130,158 | $132,426 | $2,268 | 1.74 % | $2,268 | | | | | | News Article | History of Legg Mason Investment Counsel Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Los Angeles Capital Management And Equity Research Inc | Institution | 143,824 | New Holding | 143,824 | 100 % | $2,971,404 | $3,023,180 | $51,777 | 1.74 % | $51,777 | | | | | | News Article | History of Los Angeles Capital Management And Equity Research Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Managed Account Advisors Llc | Institution | 695,108 | Added More | 635,746 | 1070.96 % | $14,360,931 | $14,611,170 | $250,239 | 1.74 % | $228,869 | | | | | | News Article | History of Managed Account Advisors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Mason Street Advisors Llc | Institution | 49,800 | Sold Some | -500 | -0.99 % | $1,028,868 | $1,046,796 | $17,928 | 1.74 % | $-180 | | | | | | News Article | History of Mason Street Advisors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Third Avenue Small Cap Value Portfolio | Small-Cap Value | 920,932 | Added More | 188,532 | 25.74 % | $19,026,455 | $19,357,991 | $331,536 | 1.74 % | $67,872 | | | | | | News Article | History of Met Investors Series Trust - Third Avenue Small Cap Value Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Neuberger Berman Group Llc | No Data | 5,045,382 | Added More | 28,841 | 0.57 % | $104,237,592 | $106,053,930 | $1,816,338 | 1.74 % | $10,383 | | | | | | News Article | History of Neuberger Berman Group Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | New York State Common Retirement Fund | Institution | 632,979 | Added More | 4,258 | 0.67 % | $13,077,346 | $13,305,219 | $227,872 | 1.74 % | $1,533 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Northwestern Mutual Wealth Management Co | Institution | 7,103 | No Change | 0 | 0 % | $146,748 | $149,305 | $2,557 | 1.74 % | $0 | | | | | | News Article | History of Northwestern Mutual Wealth Management Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Oak Hill Platinum Partners Llc | Institution | | Sold All | -6,552 | -100 % | | | | 1.74 % | $-2,359 | | | | | | News Article | History of Oak Hill Platinum Partners Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Panagora Asset Management Inc | Institution | 94,247 | Sold Some | -10,354 | -9.89 % | $1,947,143 | $1,981,072 | $33,929 | 1.74 % | $-3,727 | | | | | | News Article | History of Panagora Asset Management Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Paradigm Asset Management Co Llc | Institution | 4,050 | No Change | 0 | 0 % | $83,673 | $85,131 | $1,458 | 1.74 % | $0 | | | | | | News Article | History of Paradigm Asset Management Co Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 28,122 | Added More | 900 | 3.30 % | $581,001 | $591,124 | $10,124 | 1.74 % | $324 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 3,715 | Sold Some | -353 | -8.67 % | $76,752 | $78,089 | $1,337 | 1.74 % | $-127 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Relational Investors Llc | Institution | 741,000 | New Holding | 741,000 | 100 % | $15,309,060 | $15,575,820 | $266,760 | 1.74 % | $266,760 | | | | | | News Article | History of Relational Investors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 1,000,948 | Added More | 486,900 | 94.71 % | $20,679,586 | $21,039,927 | $360,341 | 1.74 % | $175,284 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Research Affiliates Llc | Institution | 22,036 | Added More | 750 | 3.52 % | $455,264 | $463,197 | $7,933 | 1.74 % | $270 | | | | | | News Article | History of Research Affiliates Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sei Trust Co | Institution | 900 | New Holding | 900 | 100 % | $18,594 | $18,918 | $324 | 1.74 % | $324 | | | | | | News Article | History of Sei Trust Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sentinel Asset Management Inc | Institution | 2,000 | Sold Some | -19,710 | -90.78 % | $41,320 | $42,040 | $720 | 1.74 % | $-7,096 | | | | | | News Article | History of Sentinel Asset Management Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Third Avenue Management Llc | Institution | 3,648,811 | Added More | 328,217 | 9.88 % | $75,384,435 | $76,698,007 | $1,313,572 | 1.74 % | $118,158 | | | | | | News Article | History of Third Avenue Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 3,821,618 | Added More | 40,345 | 1.06 % | $78,954,628 | $80,330,410 | $1,375,782 | 1.74 % | $14,524 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allianz Global Investors Of America L P | Institution | 21,726 | Sold Some | -54,995 | -71.68 % | $444,948 | $456,681 | $11,732 | 2.63 % | $-29,697 | | | | | | News Article | History of Allianz Global Investors Of America L P Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allstate Insurance Co | Institution | 19,201 | Sold Some | -1,202 | -5.89 % | $393,236 | $403,605 | $10,369 | 2.63 % | $-649 | | | | | | News Article | History of Allstate Insurance Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Analytic Investors Inc | Institution | 128,900 | Sold Some | -29,300 | -18.52 % | $2,639,872 | $2,709,478 | $69,606 | 2.63 % | $-15,822 | | | | | | News Article | History of Analytic Investors Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Arnhold And S Bleichroeder Advisers Llc | Institution | 12,000 | No Change | 0 | 0 % | $245,760 | $252,240 | $6,480 | 2.63 % | $0 | | | | | | News Article | History of Arnhold And S Bleichroeder Advisers Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 353,738 | Sold Some | -4,218 | -1.17 % | $7,244,554 | $7,435,573 | $191,019 | 2.63 % | $-2,278 | | | | | | News Article | History of Bank Of America Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 5,226,250 | Sold Some | -253,384 | -4.62 % | $107,033,600 | $109,855,775 | $2,822,175 | 2.63 % | $-136,827 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Boston Trust And Investment Management Co | Institution | 158,175 | New Holding | 158,175 | 100 % | $3,239,424 | $3,324,839 | $85,415 | 2.63 % | $85,415 | | | | | | News Article | History of Boston Trust And Investment Management Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Canada Pension Plan Investment Board | Institution | 100 | Sold Some | -126,700 | -99.92 % | $2,048 | $2,102 | $54 | 2.63 % | $-68,418 | | | | | | News Article | History of Canada Pension Plan Investment Board Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Chesley Taft And Associates Llc | Institution | 33,950 | Added More | 3,100 | 10.04 % | $695,296 | $713,629 | $18,333 | 2.63 % | $1,674 | | | | | | News Article | History of Chesley Taft And Associates Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Chicago Equity Partners Llc | Institution | | Sold All | -70,875 | -100 % | | | | 2.63 % | $-38,273 | | | | | | News Article | History of Chicago Equity Partners Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Corestates Capital Advisors Llc | No Data | 6,000 | Added More | 3,000 | 100.00 % | $122,880 | $126,120 | $3,240 | 2.63 % | $1,620 | | | | | | News Article | History of Corestates Capital Advisors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 54,072 | New Holding | 54,072 | 100 % | $1,107,395 | $1,136,593 | $29,199 | 2.63 % | $29,199 | | | | | | News Article | History of Credit Suisse Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Davidson D A And Co | Institution | 134,607 | Added More | 7,050 | 5.52 % | $2,756,751 | $2,829,439 | $72,688 | 2.63 % | $3,807 | | | | | | News Article | History of Davidson D A And Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Davidson Investment Advisors | Institution | 134,607 | Sold Some | -139,598 | -50.91 % | $2,756,751 | $2,829,439 | $72,688 | 2.63 % | $-75,383 | | | | | | News Article | History of Davidson Investment Advisors Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Eden Capital Management Partners Lp | Institution | | Sold All | -15,400 | -100 % | | | | 2.63 % | $-8,316 | | | | | | News Article | History of Eden Capital Management Partners Lp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Findlay Park Partners Llp | Institution | 535,300 | Added More | 90,000 | 20.21 % | $10,962,944 | $11,252,006 | $289,062 | 2.63 % | $48,600 | | | | | | News Article | History of Findlay Park Partners Llp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | First Commonwealth Financial Corp | Institution | | Sold All | -22,135 | -100 % | | | | 2.63 % | $-11,953 | | | | | | News Article | History of First Commonwealth Financial Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | First Quadrant L P | Institution | 23,700 | Added More | 7,700 | 48.12 % | $485,376 | $498,174 | $12,798 | 2.63 % | $4,158 | | | | | | News Article | History of First Quadrant L P Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | First Trust Advisors Lp | Institution | 21,008 | Added More | 6,681 | 46.63 % | $430,244 | $441,588 | $11,344 | 2.63 % | $3,608 | | | | | | News Article | History of First Trust Advisors Lp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Fortis Investments Management Usa Inc | Institution | 90,260 | Added More | 52,610 | 139.73 % | $1,848,525 | $1,897,265 | $48,740 | 2.63 % | $28,409 | | | | | | News Article | History of Fortis Investments Management Usa Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Foyston Gordon And Payne Inc | Institution | 283,411 | New Holding | 283,411 | 100 % | $5,804,257 | $5,957,299 | $153,042 | 2.63 % | $153,042 | | | | | | News Article | History of Foyston Gordon And Payne Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Franklin Resources Inc | Institution | 5,061,507 | Added More | 303,003 | 6.36 % | $103,659,663 | $106,392,877 | $2,733,214 | 2.63 % | $163,622 | | | | | | News Article | History of Franklin Resources Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Globeflex Capital L P | Institution | | Sold All | -5,600 | -100 % | | | | 2.63 % | $-3,024 | | | | | | News Article | History of Globeflex Capital L P Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Great West Life Assurance Co | Institution | 1,531,671 | Added More | 1,003,771 | 190.14 % | $31,368,622 | $32,195,724 | $827,102 | 2.63 % | $542,036 | | | | | | News Article | History of Great West Life Assurance Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 172,414 | Sold Some | -65,400 | -27.50 % | $3,531,039 | $3,624,142 | $93,104 | 2.63 % | $-35,316 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Irish Life Investment Managers | Institution | 915 | No Change | 0 | 0 % | $18,739 | $19,233 | $494 | 2.63 % | $0 | | | | | | News Article | History of Irish Life Investment Managers Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kbc Group Nv | Institution | 14,959 | Sold Some | -20,276 | -57.54 % | $306,360 | $314,438 | $8,078 | 2.63 % | $-10,949 | | | | | | News Article | History of Kbc Group Nv Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Korea Investment Corp | No Data | | Sold All | -48,015 | -100 % | | | | 2.63 % | $-25,928 | | | | | | News Article | History of Korea Investment Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Liberty Mutual Insurance Co | Institution | 11,900 | No Change | 0 | 0 % | $243,712 | $250,138 | $6,426 | 2.63 % | $0 | | | | | | News Article | History of Liberty Mutual Insurance Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | N-Q | M Fund Inc - Frontier Capital Appreciation Fund | Specialty & Misc | 32,200 | New Holding | 32,200 | 100 % | $659,456 | $676,844 | $17,388 | 2.63 % | $17,388 | | | | | | News Article | History of M Fund Inc - Frontier Capital Appreciation Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mccarthy Group Advisors Llc | Institution | 9,300 | No Change | 0 | 0 % | $190,464 | $195,486 | $5,022 | 2.63 % | $0 | | | | | | News Article | History of Mccarthy Group Advisors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 179,095 | Added More | 125,865 | 236.45 % | $3,667,866 | $3,764,577 | $96,711 | 2.63 % | $67,967 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 210,409 | Added More | 2,251 | 1.08 % | $4,309,176 | $4,422,797 | $113,621 | 2.63 % | $1,216 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Nomura Asset Management Co Ltd | Institution | 15,570 | No Change | 0 | 0 % | $318,874 | $327,281 | $8,408 | 2.63 % | $0 | | | | | | News Article | History of Nomura Asset Management Co Ltd Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 28,255 | Added More | 8,555 | 43.42 % | $578,662 | $593,920 | $15,258 | 2.63 % | $4,620 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 67,471 | Added More | 14,597 | 27.60 % | $1,381,806 | $1,418,240 | $36,434 | 2.63 % | $7,882 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Placemark Investments Inc | Institution | 18,637 | Sold Some | -11,265 | -37.67 % | $381,686 | $391,750 | $10,064 | 2.63 % | $-6,083 | | | | | | News Article | History of Placemark Investments Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Principal Financial Group Inc | Institution | 135,456 | Added More | 3,949 | 3.00 % | $2,774,139 | $2,847,285 | $73,146 | 2.63 % | $2,132 | | | | | | News Article | History of Principal Financial Group Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Provident Trust Co | Institution | | Sold All | -17,932 | -100 % | | | | 2.63 % | $-9,683 | | | | | | News Article | History of Provident Trust Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Rbc Trust Co International Ltd | No Data | 20,000 | No Change | 0 | 0 % | $409,600 | $420,400 | $10,800 | 2.63 % | $0 | | | | | | News Article | History of Rbc Trust Co International Ltd Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Rice Hall James And Associates Llc | Institution | 154,625 | Sold Some | -143,577 | -48.14 % | $3,166,720 | $3,250,218 | $83,498 | 2.63 % | $-77,532 | | | | | | News Article | History of Rice Hall James And Associates Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Russell Frank Co | Institution | | Sold All | -17,300 | -100 % | | | | 2.63 % | $-9,342 | | | | | | News Article | History of Russell Frank Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Skba Capital Management Llc | Institution | 368,915 | New Holding | 368,915 | 100 % | $7,555,379 | $7,754,593 | $199,214 | 2.63 % | $199,214 | | | | | | News Article | History of Skba Capital Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Suntrust Banks Inc | Institution | | Sold All | -218,227 | -100 % | | | | 2.63 % | $-117,843 | | | | | | News Article | History of Suntrust Banks Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 33,536 | Sold Some | -53,091 | -61.28 % | $686,817 | $704,927 | $18,109 | 2.63 % | $-28,669 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Technical Financial Services Llc | Institution | | Sold All | -65,600 | -100 % | | | | 2.63 % | $-35,424 | | | | | | News Article | History of Technical Financial Services Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | United Services Automobile Association | Institution | 11,188 | Sold Some | -312 | -2.71 % | $229,130 | $235,172 | $6,042 | 2.63 % | $-168 | | | | | | News Article | History of United Services Automobile Association Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Voyageur Asset Management Inc | Institution | 360,146 | Sold Some | -14,331 | -3.82 % | $7,375,790 | $7,570,269 | $194,479 | 2.63 % | $-7,739 | | | | | | News Article | History of Voyageur Asset Management Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Wall Street Associates | Institution | 241,700 | Sold Some | -14,800 | -5.76 % | $4,950,016 | $5,080,534 | $130,518 | 2.63 % | $-7,992 | | | | | | News Article | History of Wall Street Associates Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Wealth Advisors Of Cincinnati Llc | Institution | | Sold All | -74,511 | -100 % | | | | 2.63 % | $-40,236 | | | | | | News Article | History of Wealth Advisors Of Cincinnati Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Wilkins Investment Counsel Inc | Institution | 87,425 | Added More | 26,650 | 43.85 % | $1,790,464 | $1,837,674 | $47,210 | 2.63 % | $14,391 | | | | | | News Article | History of Wilkins Investment Counsel Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Windcrest Discovery Investments Llc | Institution | | Sold All | -43,900 | -100 % | | | | 2.63 % | $-23,706 | | | | | | News Article | History of Windcrest Discovery Investments Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | World Asset Management Inc | Institution | 17,612 | Added More | 3,887 | 28.32 % | $360,694 | $370,204 | $9,510 | 2.63 % | $2,099 | | | | | | News Article | History of World Asset Management Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | American Century Companies Inc | Institution | 427,096 | Added More | 233,100 | 120.15 % | $8,913,494 | $8,977,558 | $64,064 | 0.71 % | $34,965 | | | | | | News Article | History of American Century Companies Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | 62,953 | Sold Some | -32,635 | -34.14 % | $1,313,829 | $1,323,272 | $9,443 | 0.71 % | $-4,895 | | | | | | News Article | History of Citigroup Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Comerica Bank | Institution | 148,693 | Added More | 17,712 | 13.52 % | $3,103,223 | $3,125,527 | $22,304 | 0.71 % | $2,657 | | | | | | News Article | History of Comerica Bank Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Dai Ichi Mutual Life Insurance Co | Institution | 3,304 | No Change | 0 | 0 % | $68,954 | $69,450 | $496 | 0.71 % | $0 | | | | | | News Article | History of Dai Ichi Mutual Life Insurance Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Dlibj Asset Management Co Ltd | Institution | 16,655 | No Change | 0 | 0 % | $347,590 | $350,088 | $2,498 | 0.71 % | $0 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | First National Trust Co | Institution | | Sold All | -1,069 | -100 % | | | | 0.71 % | $-160 | | | | | | News Article | History of First National Trust Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Glenmede Trust Co Na | Institution | 1,650 | Sold Some | -87 | -5.00 % | $34,436 | $34,683 | $248 | 0.71 % | $-13 | | | | | | News Article | History of Glenmede Trust Co Na Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Highbridge Capital Management Llc | Institution | 172,502 | Sold Some | -570,845 | -76.79 % | $3,600,117 | $3,625,992 | $25,875 | 0.71 % | $-85,627 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 252,594 | Added More | 16,660 | 7.06 % | $5,271,637 | $5,309,526 | $37,889 | 0.71 % | $2,499 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Md Sass Investors Services Inc | Institution | 778,250 | Sold Some | -366,700 | -32.02 % | $16,242,078 | $16,358,815 | $116,738 | 0.71 % | $-55,005 | | | | | | News Article | History of Md Sass Investors Services Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Pax World Management Corp | Institution | 40,747 | Sold Some | -203,300 | -83.30 % | $850,390 | $856,502 | $6,112 | 0.71 % | $-30,495 | | | | | | News Article | History of Pax World Management Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Platte River Capital Llc | Institution | 86,010 | New Holding | 86,010 | 100 % | $1,795,029 | $1,807,930 | $12,902 | 0.71 % | $12,902 | | | | | | News Article | History of Platte River Capital Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Royce And Associates Llc | Institution | 3,919,228 | Added More | 2,577,929 | 192.19 % | $81,794,288 | $82,382,173 | $587,884 | 0.71 % | $386,689 | | | | | | News Article | History of Royce And Associates Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Springbank Value Partners Lp | Institution | 156,500 | Added More | 23,000 | 17.22 % | $3,266,155 | $3,289,630 | $23,475 | 0.71 % | $3,450 | | | | | | News Article | History of Springbank Value Partners Lp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Tesseract Capital Llc | No Data | | Sold All | -5,988 | -100 % | | | | 0.71 % | $-898 | | | | | | News Article | History of Tesseract Capital Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 46,883 | Added More | 896 | 1.94 % | $978,448 | $985,481 | $7,032 | 0.71 % | $134 | | | | | | News Article | History of Ubs Ag Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Value Holdings Lp | Institution | 195,676 | Added More | 21,000 | 12.02 % | $4,083,758 | $4,113,110 | $29,351 | 0.71 % | $3,150 | | | | | | News Article | History of Value Holdings Lp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Verizon Communications Inc | Institution | 9,743 | No Change | 0 | 0 % | $203,336 | $204,798 | $1,461 | 0.71 % | $0 | | | | | | News Article | History of Verizon Communications Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | William Harris Investors Inc | Institution | 226,100 | No Change | 0 | 0 % | $4,718,707 | $4,752,622 | $33,915 | 0.71 % | $0 | | | | | | News Article | History of William Harris Investors Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-06-30 | 13F-HR/A | Dlibj Asset Management Co Ltd | Institution | 16,655 | Sold Some | -359 | -2.11 % | $347,590 | $350,088 | $2,498 | 0.71 % | $-54 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2009-03-31 | 13F-HR/A | Dlibj Asset Management Co Ltd | Institution | 17,014 | Added More | 3,487 | 25.77 % | $355,082 | $357,634 | $2,552 | 0.71 % | $523 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-10 | 2008-12-31 | 13F-HR/A | Dlibj Asset Management Co Ltd | Institution | 13,527 | Sold Some | -7,802 | -36.57 % | $282,308 | $284,338 | $2,029 | 0.71 % | $-1,170 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Ccm Partners | Institution | 17,864 | Sold Some | -1,680 | -8.59 % | $373,179 | $375,501 | $2,322 | 0.62 % | $-218 | | | | | | News Article | History of Ccm Partners Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Chartwell Investment Partners | Institution | | Sold All | -511,230 | -100 % | | | | 0.62 % | $-66,460 | | | | | | News Article | History of Chartwell Investment Partners Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Fan Asset Management Llc | Institution | | Sold All | -5,600 | -100 % | | | | 0.62 % | $-728 | | | | | | News Article | History of Fan Asset Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 935,943 | New Holding | 935,943 | 100 % | $19,551,849 | $19,673,522 | $121,673 | 0.62 % | $121,673 | | | | | | News Article | History of Federated Investors Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Intrepid Capital Management Inc | No Data | 55,710 | New Holding | 55,710 | 100 % | $1,163,782 | $1,171,024 | $7,242 | 0.62 % | $7,242 | | | | | | News Article | History of Intrepid Capital Management Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Reilly Financial Advisors Llc | Institution | 470 | No Change | 0 | 0 % | $9,818 | $9,879 | $61 | 0.62 % | $0 | | | | | | News Article | History of Reilly Financial Advisors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | State Of Wisconsin Investment Board | Institution | 636,767 | Sold Some | -7,240 | -1.12 % | $13,302,063 | $13,384,842 | $82,780 | 0.62 % | $-941 | | | | | | News Article | History of State Of Wisconsin Investment Board Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Tamro Capital Partners Llc | No Data | 321,822 | Sold Some | -268,070 | -45.44 % | $6,722,862 | $6,764,698 | $41,837 | 0.62 % | $-34,849 | | | | | | News Article | History of Tamro Capital Partners Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Vtl Associates Llc | Institution | | Sold All | -59 | -100 % | | | | 0.62 % | $-8 | | | | | | News Article | History of Vtl Associates Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-09 | 2009-08-31 | N-CSR | American Performance Funds - Balanced Fund | Flexible Portfolio | 2,145 | No Change | 0 | 0 % | $44,809 | $45,088 | $279 | 0.62 % | $0 | | | | | | News Article | History of American Performance Funds - Balanced Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR/A | Baird Robert W And Co Inc | Institution | 40,849 | Sold Some | -14,785 | -26.57 % | $854,970 | $858,646 | $3,676 | 0.43 % | $-1,331 | | | | | | News Article | History of Baird Robert W And Co Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Blair William And Co | Institution | 84,602 | Sold Some | -561,024 | -86.89 % | $1,770,720 | $1,778,334 | $7,614 | 0.43 % | $-50,492 | | | | | | News Article | History of Blair William And Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Condor Capital Management | Institution | 17,215 | Sold Some | -257 | -1.47 % | $360,310 | $361,859 | $1,549 | 0.43 % | $-23 | | | | | | News Article | History of Condor Capital Management Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Hartford Investment Management Co | Institution | 32,053 | Sold Some | -100 | -0.31 % | $670,869 | $673,754 | $2,885 | 0.43 % | $-9 | | | | | | News Article | History of Hartford Investment Management Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 57,767 | Added More | 878 | 1.54 % | $1,209,063 | $1,214,262 | $5,199 | 0.43 % | $79 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 12,099 | Sold Some | -169,400 | -93.33 % | $253,232 | $254,321 | $1,089 | 0.43 % | $-15,246 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 59,814 | Added More | 2,068 | 3.58 % | $1,251,907 | $1,257,290 | $5,383 | 0.43 % | $186 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 30,440 | Added More | 740 | 2.49 % | $637,109 | $639,849 | $2,740 | 0.43 % | $67 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 538,168 | Sold Some | -500 | -0.09 % | $11,263,856 | $11,312,291 | $48,435 | 0.43 % | $-45 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Unionbancal Corp | Institution | 12,406 | Added More | 200 | 1.63 % | $259,658 | $260,774 | $1,117 | 0.43 % | $18 | | | | | | News Article | History of Unionbancal Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-06 | 2009-06-30 | 13F-HR | Condor Capital Management | Institution | 17,472 | Added More | 400 | 2.34 % | $365,689 | $367,261 | $1,572 | 0.43 % | $36 | | | | | | News Article | History of Condor Capital Management Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-06 | 2009-03-31 | 13F-HR | Condor Capital Management | Institution | 17,072 | New Holding | 17,072 | 100 % | $357,317 | $358,853 | $1,536 | 0.43 % | $1,536 | | | | | | News Article | History of Condor Capital Management Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Aster Investment Management Co Inc | Institution | 17,300 | New Holding | 17,300 | 100 % | $365,376 | $363,646 | $-1,730 | -0.47 % | $-1,730 | | | | | | News Article | History of Aster Investment Management Co Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Bank Of Hawaii | Institution | 10,840 | Sold Some | -3,270 | -23.17 % | $228,941 | $227,857 | $-1,084 | -0.47 % | $327 | | | | | | News Article | History of Bank Of Hawaii Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Fiduciary Services Corp | Institution | 12,048 | New Holding | 12,048 | 100 % | $254,454 | $253,249 | $-1,205 | -0.47 % | $-1,205 | | | | | | News Article | History of Fiduciary Services Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Fixed Income Securities Lp | Institution | 24,489 | Sold Some | -2,304 | -8.59 % | $517,208 | $514,759 | $-2,449 | -0.47 % | $230 | | | | | | News Article | History of Fixed Income Securities Lp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | High Point Bank And Trust Co | Institution | 170 | Sold Some | -105 | -38.18 % | $3,590 | $3,573 | $-17 | -0.47 % | $11 | | | | | | News Article | History of High Point Bank And Trust Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Kornitzer Capital Management Inc | Institution | 2,486,634 | Added More | 76,675 | 3.18 % | $52,517,710 | $52,269,047 | $-248,663 | -0.47 % | $-7,668 | | | | | | News Article | History of Kornitzer Capital Management Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Mitsubishi Ufj Asset Management Co Ltd | No Data | 31,800 | Sold Some | -2,500 | -7.28 % | $671,616 | $668,436 | $-3,180 | -0.47 % | $250 | | | | | | News Article | History of Mitsubishi Ufj Asset Management Co Ltd Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Nisa Investment Advisors L L C | Institution | 36,800 | Sold Some | -20,130 | -35.35 % | $777,216 | $773,536 | $-3,680 | -0.47 % | $2,013 | | | | | | News Article | History of Nisa Investment Advisors L L C Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 100,699 | Sold Some | -7,307 | -6.76 % | $2,126,763 | $2,116,693 | $-10,070 | -0.47 % | $731 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Profund Advisors Llc | Institution | 41,556 | Added More | 6,062 | 17.07 % | $877,663 | $873,507 | $-4,156 | -0.47 % | $-606 | | | | | | News Article | History of Profund Advisors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | 70,302 | Sold Some | -31,340 | -30.83 % | $1,484,778 | $1,477,748 | $-7,030 | -0.47 % | $3,134 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Teacher Retirement System Of Texas | Institution | 157,005 | Sold Some | -2,284 | -1.43 % | $3,315,946 | $3,300,245 | $-15,701 | -0.47 % | $228 | | | | | | News Article | History of Teacher Retirement System Of Texas Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Value Line Inc | Institution | 27,000 | Sold Some | -126,000 | -82.35 % | $570,240 | $567,540 | $-2,700 | -0.47 % | $12,600 | | | | | | News Article | History of Value Line Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Botti Brown Asset Management Llc | Institution | 669,600 | New Holding | 669,600 | 100 % | $14,048,208 | $14,074,992 | $26,784 | 0.19 % | $26,784 | | | | | | News Article | History of Botti Brown Asset Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Curian Capital Llc | Institution | 22,766 | Added More | 3,295 | 16.92 % | $477,631 | $478,541 | $911 | 0.19 % | $132 | | | | | | News Article | History of Curian Capital Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Frontier Capital Management Co Inc | Institution | 367,900 | Added More | 500 | 0.13 % | $7,718,542 | $7,733,258 | $14,716 | 0.19 % | $20 | | | | | | News Article | History of Frontier Capital Management Co Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Gw Capital Management Incco | Institution | 3,307 | No Change | 0 | 0 % | $69,381 | $69,513 | $132 | 0.19 % | $0 | | | | | | News Article | History of Gw Capital Management Incco Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Lehrer Management Co Inc | Institution | 23,109 | New Holding | 23,109 | 100 % | $484,827 | $485,751 | $924 | 0.19 % | $924 | | | | | | News Article | History of Lehrer Management Co Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Mitsubishi Ufj Trust Banking Corp | No Data | 85,847 | No Change | 0 | 0 % | $1,801,070 | $1,804,504 | $3,434 | 0.19 % | $0 | | | | | | News Article | History of Mitsubishi Ufj Trust Banking Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Optimum Investment Advisors | Institution | | Sold All | -10,300 | -100 % | | | | 0.19 % | $-412 | | | | | | News Article | History of Optimum Investment Advisors Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-04 | 2009-08-31 | N-CSRS | Gmo Trust - Gmo Value Fund | Multi-Cap Value | | Sold All | -100 | -100 % | | | | 0.19 % | $-4 | | | | | | News Article | History of Gmo Trust - Gmo Value Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Apg All Pensions Group | Institution | 10,470 | Sold Some | -8,000 | -43.31 % | $221,859 | $220,079 | $-1,780 | -0.80 % | $1,360 | | | | | | News Article | History of Apg All Pensions Group Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR/A | Cohen Klingenstein Llc | No Data | 23,465 | Sold Some | -2,650 | -10.14 % | $497,223 | $493,234 | $-3,989 | -0.80 % | $451 | | | | | | News Article | History of Cohen Klingenstein Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Private Trust Co Na | Institution | | Sold All | -317 | -100 % | | | | -0.80 % | $54 | | | | | | News Article | History of Private Trust Co Na Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Prudential Financial Inc | Institution | 55,486 | Sold Some | -57,275 | -50.79 % | $1,175,748 | $1,166,316 | $-9,433 | -0.80 % | $9,737 | | | | | | News Article | History of Prudential Financial Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-03 | 2009-08-31 | N-CSR | California Investment Trust - S And P Midcap Index Fund | Mid-Cap Core | 16,620 | Sold Some | -1,680 | -9.18 % | $352,178 | $349,352 | $-2,825 | -0.80 % | $286 | | | | | | News Article | History of California Investment Trust - S And P Midcap Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-03 | 2009-06-30 | 13F-HR/A | Cohen Klingenstein Llc | No Data | 26,115 | Added More | 40 | 0.15 % | $553,377 | $548,937 | $-4,440 | -0.80 % | $-7 | | | | | | News Article | History of Cohen Klingenstein Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR/A | Advanced Investment Partners Llc | No Data | 30,273 | Added More | 678 | 2.29 % | $647,237 | $636,338 | $-10,898 | -1.68 % | $-244 | | | | | | News Article | History of Advanced Investment Partners Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Arcadia Investment Management Corp | Institution | 66,942 | Added More | 5,150 | 8.33 % | $1,431,220 | $1,407,121 | $-24,099 | -1.68 % | $-1,854 | | | | | | News Article | History of Arcadia Investment Management Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Bbva Usa Bancshares Inc | Institution | 15,003 | Sold Some | -7,216 | -32.47 % | $320,764 | $315,363 | $-5,401 | -1.68 % | $2,598 | | | | | | News Article | History of Bbva Usa Bancshares Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Citizens Bank Wealth Management Na | Institution | 8,347 | Added More | 8,149 | 4115.65 % | $178,459 | $175,454 | $-3,005 | -1.68 % | $-2,934 | | | | | | News Article | History of Citizens Bank Wealth Management Na Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Deltec Asset Management Llc | Institution | | Sold All | -57,700 | -100 % | | | | -1.68 % | $20,772 | | | | | | News Article | History of Deltec Asset Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Ncm Capital Advisers Inc | Institution | 162,181 | New Holding | 162,181 | 100 % | $3,467,430 | $3,409,045 | $-58,385 | -1.68 % | $-58,385 | | | | | | News Article | History of Ncm Capital Advisers Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Ncm Capital Management Group Inc | Institution | 3,075 | New Holding | 3,075 | 100 % | $65,744 | $64,637 | $-1,107 | -1.68 % | $-1,107 | | | | | | News Article | History of Ncm Capital Management Group Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Rodgers Brothers Inc | Institution | 11,550 | Added More | 2,000 | 20.94 % | $246,939 | $242,781 | $-4,158 | -1.68 % | $-720 | | | | | | News Article | History of Rodgers Brothers Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Thrivent Financial For Lutherans | Institution | 11,600 | Sold Some | -12,400 | -51.66 % | $248,008 | $243,832 | $-4,176 | -1.68 % | $4,464 | | | | | | News Article | History of Thrivent Financial For Lutherans Ownership Of Pharmaceutical Product Development Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Valicenti Advisory Services Inc | Institution | | Sold All | -11,525 | -100 % | | | | -1.68 % | $4,149 | | | | | | News Article | History of Valicenti Advisory Services Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Connable Office Inc | Institution | 18,097 | Added More | 1,014 | 5.93 % | $389,990 | $380,399 | $-9,591 | -2.45 % | $-537 | | | | | | News Article | History of Connable Office Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Robeco Investment Management Inc | Institution | | Sold All | -9,293 | -100 % | | | | -2.45 % | $4,925 | | | | | | News Article | History of Robeco Investment Management Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Sit Investment Associates Inc | Institution | 31,500 | Sold Some | -34,500 | -52.27 % | $678,825 | $662,130 | $-16,695 | -2.45 % | $18,285 | | | | | | News Article | History of Sit Investment Associates Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Spears Abacus Advisors Llc | Institution | 33,021 | Added More | 250 | 0.76 % | $711,603 | $694,101 | $-17,501 | -2.45 % | $-133 | | | | | | News Article | History of Spears Abacus Advisors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Texas Permanent School Fund | Institution | 189,789 | Sold Some | -1,553 | -0.81 % | $4,089,953 | $3,989,365 | $-100,588 | -2.45 % | $823 | | | | | | News Article | History of Texas Permanent School Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Tocqueville Asset Management Lp | Institution | 265,653 | Added More | 56,601 | 27.07 % | $5,724,822 | $5,584,026 | $-140,796 | -2.45 % | $-29,999 | | | | | | News Article | History of Tocqueville Asset Management Lp Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Mercantile Funds Inc - Mercantile Capital Opportunities Fund | Specialty & Misc | | Sold All | -3,600 | -100 % | | | | -2.45 % | $1,908 | | | | | | News Article | History of Mercantile Funds Inc - Mercantile Capital Opportunities Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Health Care Index Fund | Health/Biotech | | Sold All | -50,296 | -100 % | | | | -2.45 % | $26,657 | | | | | | News Article | History of Vanguard World Fund - Vanguard Health Care Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 56,300 | Added More | 200 | 0.35 % | $1,230,155 | $1,183,426 | $-46,729 | -3.79 % | $-166 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Inview Investment Management Llc | Institution | 193,450 | Added More | 5,100 | 2.70 % | $4,226,883 | $4,066,319 | $-160,564 | -3.79 % | $-4,233 | | | | | | News Article | History of Inview Investment Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | John G Ullman And Associates Inc | Institution | 37,450 | Sold Some | -1,400 | -3.60 % | $818,283 | $787,199 | $-31,084 | -3.79 % | $1,162 | | | | | | News Article | History of John G Ullman And Associates Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Roaring Brook Capital L P | No Data | 123,600 | Added More | 33,600 | 37.33 % | $2,700,660 | $2,598,072 | $-102,588 | -3.79 % | $-27,888 | | | | | | News Article | History of Roaring Brook Capital L P Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Evergreen Equity Trust De - Evergreen Market Index Growth Fund | Multi-Cap Growth | 9,416 | Sold Some | -1,147 | -10.85 % | $205,740 | $197,924 | $-7,815 | -3.79 % | $952 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Market Index Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Unified Series Trust - Marathon Value Portfolio | Multi-Cap Value | | Sold All | -15,200 | -100 % | | | | -3.79 % | $12,616 | | | | | | News Article | History of Unified Series Trust - Marathon Value Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | | Sold All | -5,400 | -100 % | | | | -3.79 % | $4,482 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | | Sold All | -300 | -100 % | | | | -3.79 % | $249 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Kalmar Investments Inc | Institution | | Sold All | -597,740 | -100 % | | | | -4.49 % | $591,763 | | | | | | News Article | History of Kalmar Investments Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Dws Securities Trust - Dws Health Care Fund | Health/Biotech | 38,000 | No Change | 0 | 0 % | $836,380 | $798,760 | $-37,620 | -4.49 % | $0 | | | | | | News Article | History of Dws Securities Trust - Dws Health Care Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Proshares Trust - Ultra Qqq Proshares | Specialty & Misc | 57,113 | Sold Some | -61,265 | -51.75 % | $1,257,057 | $1,200,515 | $-56,542 | -4.49 % | $60,652 | | | | | | News Article | History of Proshares Trust - Ultra Qqq Proshares Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Forward Management Llc | Institution | | Sold All | -300 | -100 % | | | | -10.01 % | $702 | | | | | | News Article | History of Forward Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Mesirow Financial Investment Management | Institution | 13,850 | Sold Some | -132 | -0.94 % | $323,536 | $291,127 | $-32,409 | -10.01 % | $309 | | | | | | News Article | History of Mesirow Financial Investment Management Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Nicholas Co Inc | Institution | 200,400 | Sold Some | -19,900 | -9.03 % | $4,681,344 | $4,212,408 | $-468,936 | -10.01 % | $46,566 | | | | | | News Article | History of Nicholas Co Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Seaward Management Corp | Institution | 57,285 | Sold Some | -23,445 | -29.04 % | $1,338,178 | $1,204,131 | $-134,047 | -10.01 % | $54,861 | | | | | | News Article | History of Seaward Management Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Hershey Trust Co | Institution | 242,706 | New Holding | 242,706 | 100 % | $5,587,092 | $5,101,680 | $-485,412 | -8.68 % | $-485,412 | | | | | | News Article | History of Hershey Trust Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Schroder Investment Management Group | Institution | 1,186,862 | Added More | 555,395 | 87.95 % | $27,321,563 | $24,947,839 | $-2,373,724 | -8.68 % | $-1,110,790 | | | | | | News Article | History of Schroder Investment Management Group Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf | Specialty & Misc | 57 | No Change | 0 | 0 % | $1,312 | $1,198 | $-114 | -8.68 % | $0 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Ing Series Fund Inc - Ing Balanced Fund | Mixed-Asset Target Allocation Moderate | 3,078 | New Holding | 3,078 | 100 % | $70,856 | $64,700 | $-6,156 | -8.68 % | $-6,156 | | | | | | News Article | History of Ing Series Fund Inc - Ing Balanced Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Ing Series Fund Inc - Ing Index Plus Midcap Fund | Mid-Cap Core | 41,052 | Added More | 8,800 | 27.28 % | $945,017 | $862,913 | $-82,104 | -8.68 % | $-17,600 | | | | | | News Article | History of Ing Series Fund Inc - Ing Index Plus Midcap Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Legg Mason Partners Equity Trust - Legg Mason Partners Mid Cap Core Fund | Mid-Cap Core | | Sold All | -400,000 | -100 % | | | | -8.68 % | $800,000 | | | | | | News Article | History of Legg Mason Partners Equity Trust - Legg Mason Partners Mid Cap Core Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 638,949 | Added More | 520,496 | 439.41 % | $14,708,606 | $13,430,708 | $-1,277,898 | -8.68 % | $-1,040,992 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Gateway Investment Advisers Lp | Institution | 9,242 | New Holding | 9,242 | 100 % | $213,028 | $194,267 | $-18,761 | -8.80 % | $-18,761 | | | | | | News Article | History of Gateway Investment Advisers Lp Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Mountain Pacific Investment Advisers Inc | Institution | | Sold All | -149,400 | -100 % | | | | -8.80 % | $303,282 | | | | | | News Article | History of Mountain Pacific Investment Advisers Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Rbc Bank Usa Trust Department | No Data | | Sold All | -7,125 | -100 % | | | | -8.80 % | $14,464 | | | | | | News Article | History of Rbc Bank Usa Trust Department Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Advisors Llc | Institution | 226,400 | New Holding | 226,400 | 100 % | $5,365,680 | $4,758,928 | $-606,752 | -11.30 % | $-606,752 | | | | | | News Article | History of Blackrock Advisors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 37,367 | No Change | 0 | 0 % | $885,598 | $785,454 | $-100,144 | -11.30 % | $0 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | 5,410 | Sold Some | -33,032 | -85.92 % | $128,217 | $113,718 | $-14,499 | -11.30 % | $88,526 | | | | | | News Article | History of Blackrock Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 374,675 | Added More | 147,846 | 65.17 % | $8,879,798 | $7,875,669 | $-1,004,129 | -11.30 % | $-396,227 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Congress Asset Management Co | Institution | | Sold All | -179,802 | -100 % | | | | -11.30 % | $481,869 | | | | | | News Article | History of Congress Asset Management Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Farmers And Merchants Investments Inc | Institution | 163 | New Holding | 163 | 100 % | $3,863 | $3,426 | $-437 | -11.30 % | $-437 | | | | | | News Article | History of Farmers And Merchants Investments Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Merrill Lynch Mercury Asset Management Japan Ltd | Institution | 95,900 | Sold Some | -256 | -0.26 % | $2,272,830 | $2,015,818 | $-257,012 | -11.30 % | $686 | | | | | | News Article | History of Merrill Lynch Mercury Asset Management Japan Ltd Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Oakbrook Investments Llc | Institution | | Sold All | -21,050 | -100 % | | | | -11.30 % | $56,414 | | | | | | News Article | History of Oakbrook Investments Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 2,193,285 | Sold Some | -41,405 | -1.85 % | $50,094,629 | $46,102,851 | $-3,991,779 | -7.96 % | $75,357 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Firstmerit Bank N A Trustee | Institution | 15,819 | New Holding | 15,819 | 100 % | $361,306 | $332,515 | $-28,791 | -7.96 % | $-28,791 | | | | | | News Article | History of Firstmerit Bank N A Trustee Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | River Road Asset Management Llc | Institution | 709,655 | Added More | 182,775 | 34.69 % | $16,208,520 | $14,916,948 | $-1,291,572 | -7.96 % | $-332,651 | | | | | | News Article | History of River Road Asset Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 331,317 | Added More | 48,250 | 17.04 % | $7,567,280 | $6,964,283 | $-602,997 | -7.96 % | $-87,815 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Stifel Nicolaus And Co Inc Mo | Institution | | Sold All | -12,184 | -100 % | | | | -7.96 % | $22,175 | | | | | | News Article | History of Stifel Nicolaus And Co Inc Mo Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-21 | 2009-06-30 | 13F-HR/A | Rbc Trust Co International Ltd | No Data | 20,000 | New Holding | 20,000 | 100 % | $456,800 | $420,400 | $-36,400 | -7.96 % | $-36,400 | | | | | | News Article | History of Rbc Trust Co International Ltd Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | American Capital Management Inc | Institution | 769,300 | Added More | 54,695 | 7.65 % | $17,324,636 | $16,170,686 | $-1,153,950 | -6.66 % | $-82,043 | | | | | | News Article | History of American Capital Management Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-20 | 2009-09-30 | N-Q | Foresight Funds Inc - Foresight Value Fund | Multi-Cap Value | 1,000 | New Holding | 1,000 | 100 % | $22,520 | $21,020 | $-1,500 | -6.66 % | $-1,500 | | | | | | News Article | History of Foresight Funds Inc - Foresight Value Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 189,600 | No Change | 0 | 0 % | $4,269,792 | $3,985,392 | $-284,400 | -6.66 % | $0 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Teachers Retirement System Of The State Of Kentucky | Institution | 53,000 | Sold Some | -36,400 | -40.71 % | $1,193,560 | $1,114,060 | $-79,500 | -6.66 % | $54,600 | | | | | | News Article | History of Teachers Retirement System Of The State Of Kentucky Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | American National Bank And Trust Co | Institution | 150,630 | Added More | 12,850 | 9.32 % | $3,419,301 | $3,166,243 | $-253,058 | -7.40 % | $-21,588 | | | | | | News Article | History of American National Bank And Trust Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | | Sold All | -3,400 | -100 % | | | | -7.40 % | $5,712 | | | | | | News Article | History of Strs Ohio Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Capstone Asset Management Co | Institution | 9,740 | Added More | 250 | 2.63 % | $220,708 | $204,735 | $-15,974 | -7.23 % | $-410 | | | | | | News Article | History of Capstone Asset Management Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Manning And Napier Advisors Inc | Institution | | Sold All | -287,830 | -100 % | | | | -7.23 % | $472,041 | | | | | | News Article | History of Manning And Napier Advisors Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | National Bank Of Indianapolis Corp | Institution | 1,310 | Sold Some | -290 | -18.12 % | $29,685 | $27,536 | $-2,148 | -7.23 % | $476 | | | | | | News Article | History of National Bank Of Indianapolis Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Harris Financial Corp | Institution | 97,931 | Added More | 70,223 | 253.43 % | $2,248,496 | $2,058,510 | $-189,986 | -8.44 % | $-136,233 | | | | | | News Article | History of Harris Financial Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 323,706 | Sold Some | -54,978 | -14.51 % | $7,432,290 | $6,804,300 | $-627,990 | -8.44 % | $106,657 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-15 | 2008-06-30 | 13F-HR/A | Clarivest Asset Management Llc | Institution | 62,282 | Sold Some | -108,667 | -63.56 % | $1,429,995 | $1,309,168 | $-120,827 | -8.44 % | $210,814 | | | | | | News Article | History of Clarivest Asset Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-15 | 2007-03-31 | 13F-HR/A | Northwestern Mutual Life Insurance Co | Institution | | Sold All | -96 | -100 % | | | | -8.44 % | $186 | | | | | | News Article | History of Northwestern Mutual Life Insurance Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | First Citizens Bank And Trust Co | Institution | | Sold All | -9,594 | -100 % | | | | -8.24 % | $18,133 | | | | | | News Article | History of First Citizens Bank And Trust Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Granahan Investment Management Inc | Institution | 797,750 | No Change | 0 | 0 % | $18,276,453 | $16,768,705 | $-1,507,748 | -8.24 % | $0 | | | | | | News Article | History of Granahan Investment Management Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Menlo Advisors Llc | Institution | 47,605 | Sold Some | -875 | -1.80 % | $1,090,631 | $1,000,657 | $-89,973 | -8.24 % | $1,654 | | | | | | News Article | History of Menlo Advisors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Shell Asset Management Co | Institution | 22,554 | Added More | 11,718 | 108.13 % | $516,712 | $474,085 | $-42,627 | -8.24 % | $-22,147 | | | | | | News Article | History of Shell Asset Management Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-09 | 2009-09-30 | 13F-HR | Riverside Advisors Llc | Institution | | Sold All | -90,000 | -100 % | | | | -4.23 % | $83,700 | | | | | | News Article | History of Riverside Advisors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | First Trust Exchange-Traded Alphadex Fund - First Trust Health Care Alphadex Fund | Health/Biotech | | Sold All | -1,971 | -100 % | | | | -4.23 % | $1,833 | | | | | | News Article | History of First Trust Exchange-Traded Alphadex Fund - First Trust Health Care Alphadex Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Howland Capital Management Inc | Institution | 181,946 | Sold Some | -35,507 | -16.32 % | $3,995,534 | $3,824,505 | $-171,029 | -4.28 % | $33,377 | | | | | | News Article | History of Howland Capital Management Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 203,420 | Added More | 4,065 | 2.03 % | $4,467,103 | $4,275,888 | $-191,215 | -4.28 % | $-3,821 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-08 | 2008-07-31 | N-CSR | Morgan Stanley Health Sciences Trust - None | Specialty & Misc | 87,400 | No Change | 0 | 0 % | $1,919,304 | $1,837,148 | $-82,156 | -4.28 % | $0 | | | | | | News Article | History of Morgan Stanley Health Sciences Trust - None Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-07 | 2009-09-30 | 13F-HR | National Penn Investors Trust Co | Institution | 30,662 | Added More | 1,328 | 4.52 % | $675,484 | $644,515 | $-30,969 | -4.58 % | $-1,341 | | | | | | News Article | History of National Penn Investors Trust Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Aim Investment Securities Funds - Aim Income Fund | Equity Income | 296,620 | New Holding | 296,620 | 100 % | $6,534,539 | $6,234,952 | $-299,586 | -4.58 % | $-299,586 | | | | | | News Article | History of Aim Investment Securities Funds - Aim Income Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-06 | 2009-09-30 | 13F-HR | Franklin Street Advisors Inc | Institution | 30,000 | Added More | 15,000 | 100.00 % | $659,100 | $630,600 | $-28,500 | -4.32 % | $-14,250 | | | | | | News Article | History of Franklin Street Advisors Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-05 | 2009-09-30 | 13F-HR | Denali Advisors Llc | Institution | | Sold All | -31,300 | -100 % | | | | -3.04 % | $20,658 | | | | | | News Article | History of Denali Advisors Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-05 | 2009-09-30 | 13F-HR | Neville Rodie And Shaw Inc | Institution | | Sold All | -17,600 | -100 % | | | | -3.04 % | $11,616 | | | | | | News Article | History of Neville Rodie And Shaw Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Pacific Capital Funds - Value Fund | Multi-Cap Core | 2,300 | Sold Some | -3,600 | -61.01 % | $49,381 | $48,346 | $-1,035 | -2.09 % | $1,620 | | | | | | News Article | History of Pacific Capital Funds - Value Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | 300 | New Holding | 300 | 100 % | $6,441 | $6,306 | $-135 | -2.09 % | $-135 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | | Sold All | -10,000 | -100 % | | | | -2.09 % | $4,500 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Aim Equity Funds - Aim Capital Development Fund | Mid-Cap Growth | | Sold All | -173,290 | -100 % | | | | -3.62 % | $136,899 | | | | | | News Article | History of Aim Equity Funds - Aim Capital Development Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Independence Funds Trust - Fusion Fund | No Data | | Sold All | -554 | -100 % | | | | -3.62 % | $438 | | | | | | News Article | History of American Independence Funds Trust - Fusion Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dws Blue Chip Fund - Dws Blue Chip Fund | Multi-Cap Core | | Sold All | -8,600 | -100 % | | | | -3.62 % | $6,794 | | | | | | News Article | History of Dws Blue Chip Fund - Dws Blue Chip Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Evergreen Equity Trust De - Evergreen Health Care Fund | Health/Biotech | | Sold All | -74,443 | -100 % | | | | -3.62 % | $58,810 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Health Care Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Morningstar Mid Growth Index Fund | Mid-Cap Growth | 24,904 | Sold Some | -9,168 | -26.90 % | $543,156 | $523,482 | $-19,674 | -3.62 % | $7,243 | | | | | | News Article | History of Ishares Trust - Ishares Morningstar Mid Growth Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Index 5 Fund | Specialty & Misc | 1,420 | No Change | 0 | 0 % | $30,970 | $29,848 | $-1,122 | -3.62 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Index 5 Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Optimized 5 Fund | Specialty & Misc | 1,381 | Sold Some | -356 | -20.49 % | $30,120 | $29,029 | $-1,091 | -3.62 % | $281 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Optimized 5 Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Vip Fund | No Data | 78 | Sold Some | -35 | -30.97 % | $1,701 | $1,640 | $-62 | -3.62 % | $28 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Vip Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Mainstay Funds - Mainstay Common Stock Fund | Large-Cap Core | | Sold All | -3,656 | -100 % | | | | -3.62 % | $2,888 | | | | | | News Article | History of Mainstay Funds - Mainstay Common Stock Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Russell Investment Co - International Fund | International Multi-Cap Core | | Sold All | -17,574 | -100 % | | | | -3.62 % | $13,883 | | | | | | News Article | History of Russell Investment Co - International Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Van Kampen Trust Ii - Global Tactical Asset Allocation Fund | No Data | 100 | No Change | 0 | 0 % | $2,181 | $2,102 | $-79 | -3.62 % | $0 | | | | | | News Article | History of Van Kampen Trust Ii - Global Tactical Asset Allocation Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard Explorer Fund - Vanguard Explorer Fund | Small-Cap Growth | 1,047,136 | Sold Some | -31,910 | -2.95 % | $22,838,036 | $22,010,799 | $-827,237 | -3.62 % | $25,209 | | | | | | News Article | History of Vanguard Explorer Fund - Vanguard Explorer Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Fbr Funds - Fbr Pegasus Fund | Multi-Cap Value | 1,930 | Added More | 130 | 7.22 % | $42,344 | $40,569 | $-1,776 | -4.19 % | $-120 | | | | | | News Article | History of Fbr Funds - Fbr Pegasus Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Fbr Funds - Fbr Pegasus Small Cap Fund | Small-Cap Growth | 5,550 | New Holding | 5,550 | 100 % | $121,767 | $116,661 | $-5,106 | -4.19 % | $-5,106 | | | | | | News Article | History of Fbr Funds - Fbr Pegasus Small Cap Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Fbr Funds - Fbr Small Cap Fund | Small-Cap Growth | | Sold All | -600 | -100 % | | | | -4.19 % | $552 | | | | | | News Article | History of Fbr Funds - Fbr Small Cap Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Franklin Value Investors Trust - Franklin All Cap Value Fund | Multi-Cap Value | 8,300 | Added More | 300 | 3.75 % | $182,102 | $174,466 | $-7,636 | -4.19 % | $-276 | | | | | | News Article | History of Franklin Value Investors Trust - Franklin All Cap Value Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Franklin Value Investors Trust - Franklin Large Cap Value Fund | Large-Cap Value | | Sold All | -35,600 | -100 % | | | | -4.19 % | $32,752 | | | | | | News Article | History of Franklin Value Investors Trust - Franklin Large Cap Value Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Harbor Funds - Harbor Small Cap Value Fund | Small-Cap Core | 664,886 | Sold Some | -80,600 | -10.81 % | $14,587,599 | $13,975,904 | $-611,695 | -4.19 % | $74,152 | | | | | | News Article | History of Harbor Funds - Harbor Small Cap Value Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Legg Mason Partners Equity Trust - Legg Mason Partners Dividend Strategy Fund | Specialty & Misc | | Sold All | -120,000 | -100 % | | | | -4.19 % | $110,400 | | | | | | News Article | History of Legg Mason Partners Equity Trust - Legg Mason Partners Dividend Strategy Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Legg Mason Partners Variable Equity Trust - Legg Mason Partners Variable Dividend Strategy Portfolio | Specialty & Misc | | Sold All | -3,200 | -100 % | | | | -4.19 % | $2,944 | | | | | | News Article | History of Legg Mason Partners Variable Equity Trust - Legg Mason Partners Variable Dividend Strategy Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Legg Mason Partners Variable Equity Trust - Legg Mason Partners Variable Mid Cap Core Portfolio | Mid-Cap Core | 37,700 | Sold Some | -2,800 | -6.91 % | $827,138 | $792,454 | $-34,684 | -4.19 % | $2,576 | | | | | | News Article | History of Legg Mason Partners Variable Equity Trust - Legg Mason Partners Variable Mid Cap Core Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 800 | New Holding | 800 | 100 % | $17,552 | $16,816 | $-736 | -4.19 % | $-736 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dividend Achievers Portfolio | Specialty & Misc | 2,600 | New Holding | 2,600 | 100 % | $57,044 | $54,652 | $-2,392 | -4.19 % | $-2,392 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dividend Achievers Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Healthcare Sector Portfolio | Health/Biotech | | Sold All | -35,895 | -100 % | | | | -4.19 % | $33,023 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Healthcare Sector Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Health Care Fund | Health/Biotech | | Sold All | -50,000 | -100 % | | | | -4.19 % | $46,000 | | | | | | News Article | History of Schwab Capital Trust - Schwab Health Care Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Tocqueville Trust - The Tocqueville Fund | Specialty & Misc | 15,000 | New Holding | 15,000 | 100 % | $329,100 | $315,300 | $-13,800 | -4.19 % | $-13,800 | | | | | | News Article | History of Tocqueville Trust - The Tocqueville Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Victory Portfolios - Victory Established Value Fund | Mid-Cap Value | 136,000 | New Holding | 136,000 | 100 % | $2,983,840 | $2,858,720 | $-125,120 | -4.19 % | $-125,120 | | | | | | News Article | History of Victory Portfolios - Victory Established Value Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Victory Portfolios - Victory Small Company Opportunity Fund | Small-Cap Value | 124,000 | New Holding | 124,000 | 100 % | $2,720,560 | $2,606,480 | $-114,080 | -4.19 % | $-114,080 | | | | | | News Article | History of Victory Portfolios - Victory Small Company Opportunity Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Victory Portfolios - Victory Special Value Fund | Mid-Cap Value | 467,600 | Sold Some | -103,587 | -18.13 % | $10,259,144 | $9,828,952 | $-430,192 | -4.19 % | $95,300 | | | | | | News Article | History of Victory Portfolios - Victory Special Value Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust - Direxion Daily Large Cap Bull 3x Shares | No Data | 8,215 | Added More | 5,663 | 221.90 % | $178,101 | $172,679 | $-5,422 | -3.04 % | $-3,738 | | | | | | News Article | History of Direxion Shares Etf Trust - Direxion Daily Large Cap Bull 3x Shares Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust - Direxion Daily Mid Cap Bull 3x Shares | No Data | 2,562 | Added More | 1,898 | 285.84 % | $55,544 | $53,853 | $-1,691 | -3.04 % | $-1,253 | | | | | | News Article | History of Direxion Shares Etf Trust - Direxion Daily Mid Cap Bull 3x Shares Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds - Mtb Mid Cap Growth Fund | Mid-Cap Growth | | Sold All | -49,500 | -100 % | | | | -3.04 % | $32,670 | | | | | | News Article | History of Mtb Group Of Funds - Mtb Mid Cap Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds - Mtb Multi Cap Growth Fund | Multi-Cap Core | | Sold All | -2,800 | -100 % | | | | -3.04 % | $1,848 | | | | | | News Article | History of Mtb Group Of Funds - Mtb Multi Cap Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Unified Series Trust - Marathon Value Portfolio | Multi-Cap Value | 15,200 | New Holding | 15,200 | 100 % | $329,536 | $319,504 | $-10,032 | -3.04 % | $-10,032 | | | | | | News Article | History of Unified Series Trust - Marathon Value Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-25 | 2009-06-30 | 13F-HR/A | Kbc Group Nv | Institution | 35,235 | Added More | 3,691 | 11.70 % | $763,895 | $740,640 | $-23,255 | -3.04 % | $-2,436 | | | | | | News Article | History of Kbc Group Nv Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-24 | 2009-07-31 | N-Q | Nationwide Mutual Funds - Nationwide Mid Cap Market Index Fund | Mid-Cap Core | | Sold All | -103,700 | -100 % | | | | -2.18 % | $48,739 | | | | | | News Article | History of Nationwide Mutual Funds - Nationwide Mid Cap Market Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-24 | 2009-06-30 | 13F-HR/A | Credit Agricole S A | Institution | 7,839 | No Change | 0 | 0 % | $168,460 | $164,776 | $-3,684 | -2.18 % | $0 | | | | | | News Article | History of Credit Agricole S A Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-21 | 2009-06-30 | 13F-HR/A | Eaton Vance Management | Institution | 26,355 | New Holding | 26,355 | 100 % | $579,283 | $553,982 | $-25,301 | -4.36 % | $-25,301 | | | | | | News Article | History of Eaton Vance Management Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-21 | 2009-06-30 | 13F-HR/A | Eaton Vance Management | Institution | 27,089 | New Holding | 27,089 | 100 % | $595,416 | $569,411 | $-26,005 | -4.36 % | $-26,005 | | | | | | News Article | History of Eaton Vance Management Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - S And P Midcap 400 Pure Growth Etf | Mid-Cap Growth | 6,938 | New Holding | 6,938 | 100 % | $156,521 | $145,837 | $-10,685 | -6.82 % | $-10,685 | | | | | | News Article | History of Rydex Etf Trust - S And P Midcap 400 Pure Growth Etf Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-17 | 2009-06-30 | 13F-HR/A | Delaware Management Business Trust | Institution | 178,800 | New Holding | 178,800 | 100 % | $4,033,728 | $3,758,376 | $-275,352 | -6.82 % | $-275,352 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-15 | 2009-03-31 | 13F-HR/A | Highbridge Capital Management Llc | Institution | 702,659 | Added More | 393,381 | 127.19 % | $15,240,674 | $14,769,892 | $-470,782 | -3.08 % | $-263,565 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 5,479,634 | Added More | 751,740 | 15.90 % | $119,565,614 | $115,181,907 | $-4,383,707 | -3.66 % | $-601,392 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-10 | 2009-03-31 | 13F-HR/A | Veritable L P | Institution | | Sold All | -7,710 | -100 % | | | | -1.31 % | $2,159 | | | | | | News Article | History of Veritable L P Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-09 | 2009-06-30 | N-CSRS | Value Line Premier Growth Fund Inc - Value Line Premier Growth Fund Inc | Large-Cap Growth | 32,000 | No Change | 0 | 0 % | $665,920 | $672,640 | $6,720 | 1.00 % | $0 | | | | | | News Article | History of Value Line Premier Growth Fund Inc - Value Line Premier Growth Fund Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-09 | 2009-06-30 | N-CSRS | Value Line Strategic Asset Management Trust - Value Line Strategic Asset Management Trust | Multi-Cap Value | 52,000 | No Change | 0 | 0 % | $1,082,120 | $1,093,040 | $10,920 | 1.00 % | $0 | | | | | | News Article | History of Value Line Strategic Asset Management Trust - Value Line Strategic Asset Management Trust Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Allianz Variable Insurance Products Trust - Azl Franklin Small Cap Value Fund | Small-Cap Value | 94,600 | New Holding | 94,600 | 100 % | $1,909,974 | $1,988,492 | $78,518 | 4.11 % | $78,518 | | | | | | News Article | History of Allianz Variable Insurance Products Trust - Azl Franklin Small Cap Value Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Allianz Variable Insurance Products Trust - Azl Mid Cap Index Fund | No Data | 4,594 | No Compare | | | $92,753 | $96,566 | $3,813 | 4.11 % | | | | | | | News Article | History of Allianz Variable Insurance Products Trust - Azl Mid Cap Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-08 | 2009-06-30 | N-CSR | Nuveen Investment Trust - Nuveen Enhanced Mid-Cap Fund | No Data | | Sold All | -10 | -100 % | | | | 4.11 % | $-8 | | | | | | News Article | History of Nuveen Investment Trust - Nuveen Enhanced Mid-Cap Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-08 | 2009-06-30 | N-CSR | Revenueshares Etf Trust - Revenueshares Mid Cap Fund | Mid-Cap Core | | Sold All | -654 | -100 % | | | | 4.11 % | $-543 | | | | | | News Article | History of Revenueshares Etf Trust - Revenueshares Mid Cap Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 52,874 | Added More | 11,778 | 28.65 % | $1,067,526 | $1,111,411 | $43,885 | 4.11 % | $9,776 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 10,970 | Added More | 3,245 | 42.00 % | $221,484 | $230,589 | $9,105 | 4.11 % | $2,693 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Summit Mutual Funds Inc - Zenith Portfolio | Specialty & Misc | 16,302 | Sold Some | -45 | -0.27 % | $329,137 | $342,668 | $13,531 | 4.11 % | $-37 | | | | | | News Article | History of Summit Mutual Funds Inc - Zenith Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Timothy Plan - Timothy Aggressive Growth Fund | Multi-Cap Growth | 14,000 | New Holding | 14,000 | 100 % | $282,660 | $294,280 | $11,620 | 4.11 % | $11,620 | | | | | | News Article | History of Timothy Plan - Timothy Aggressive Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Ubs Relationship Funds - Ubs International Equity Relationship Fund | Global Flex Port | | Sold All | -39,000 | -100 % | | | | 4.11 % | $-32,370 | | | | | | News Article | History of Ubs Relationship Funds - Ubs International Equity Relationship Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast Advanced Strategies Portfolio | Specialty & Misc | | Sold All | -2,100 | -100 % | | | | 4.73 % | $-1,995 | | | | | | News Article | History of Advanced Series Trust - Ast Advanced Strategies Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Advisors Series Trust - Davidson Multi-Cap Core Fund | No Data | 9,380 | New Holding | 9,380 | 100 % | $188,257 | $197,168 | $8,911 | 4.73 % | $8,911 | | | | | | News Article | History of Advisors Series Trust - Davidson Multi-Cap Core Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | American Funds Insurance Series - Global Growth Fund | Global Large-Cap Growth | 544,350 | No Change | 0 | 0 % | $10,925,105 | $11,442,237 | $517,133 | 4.73 % | $0 | | | | | | News Article | History of American Funds Insurance Series - Global Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 2,500 | Sold Some | -26,000 | -91.22 % | $50,175 | $52,550 | $2,375 | 4.73 % | $-24,700 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Value Portfolio | Small-Cap Value | 176,900 | New Holding | 176,900 | 100 % | $3,550,383 | $3,718,438 | $168,055 | 4.73 % | $168,055 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Value Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Growth And Income Portfolio | Multi-Cap Growth | | Sold All | -21,600 | -100 % | | | | 4.73 % | $-20,520 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Growth And Income Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 85,100 | New Holding | 85,100 | 100 % | $1,707,957 | $1,788,802 | $80,845 | 4.73 % | $80,845 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 301,040 | Added More | 50,840 | 20.31 % | $6,041,873 | $6,327,861 | $285,988 | 4.73 % | $48,298 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqinternational Growth Portfolio | Multi-Cap Growth | 25,110 | No Change | 0 | 0 % | $503,958 | $527,812 | $23,855 | 4.73 % | $0 | | | | | | News Article | History of Eq Advisors Trust - Eqinternational Growth Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Hartford Hls Series Fund Ii Inc - Hartford Largecap Growth Hls Fund | Large-Cap Growth | 15 | Sold Some | -1 | -6.25 % | $301 | $315 | $14 | 4.73 % | $-1 | | | | | | News Article | History of Hartford Hls Series Fund Ii Inc - Hartford Largecap Growth Hls Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Hartford Hls Series Fund Ii Inc - Hartford Midcap Growth Hls Fund | Mid-Cap Growth | | Sold All | -429 | -100 % | | | | 4.73 % | $-408 | | | | | | News Article | History of Hartford Hls Series Fund Ii Inc - Hartford Midcap Growth Hls Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Hartford Series Fund Inc - Hartford Advisers Hls Fund | Specialty & Misc | 15 | Sold Some | -1 | -6.25 % | $301 | $315 | $14 | 4.73 % | $-1 | | | | | | News Article | History of Hartford Series Fund Inc - Hartford Advisers Hls Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Mma Praxis Mutual Funds - Mma Praxis Growth Index Fund | Large-Cap Growth | | Sold All | -813 | -100 % | | | | 4.73 % | $-772 | | | | | | News Article | History of Mma Praxis Mutual Funds - Mma Praxis Growth Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Blue Chip Mid Cap Fund | Mid-Cap Core | 17,000 | Sold Some | -2,800 | -14.14 % | $341,190 | $357,340 | $16,150 | 4.73 % | $-2,660 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Blue Chip Mid Cap Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Large Cap Growth | Large-Cap Growth | | Sold All | -8,080 | -100 % | | | | 4.73 % | $-7,676 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Large Cap Growth Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds - Vanguard Institutional Index Fund | Specialty & Misc | | Sold All | -96,972 | -100 % | | | | 4.73 % | $-92,123 | | | | | | News Article | History of Vanguard Institutional Index Funds - Vanguard Institutional Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Variable Insurance Funds - Balanced Portfolio | Flexible Portfolio | | Sold All | -37,205 | -100 % | | | | 4.73 % | $-35,345 | | | | | | News Article | History of Vanguard Variable Insurance Funds - Balanced Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Variable Insurance Funds - Small Company Growth Portfolio | Small-Cap Growth | | Sold All | -6,800 | -100 % | | | | 4.73 % | $-6,460 | | | | | | News Article | History of Vanguard Variable Insurance Funds - Small Company Growth Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Advantus Series Fund Inc - Index 400 Mid-Cap Portfolio | No Data | | Sold All | -17,152 | -100 % | | | | - % | | | | | | | News Article | History of Advantus Series Fund Inc - Index 400 Mid-Cap Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Ing Investors Trust - Ing Evergreen Health Sciences Portfolio | Health/Biotech | | Sold All | -107,663 | -100 % | | | | - % | | | | | | | News Article | History of Ing Investors Trust - Ing Evergreen Health Sciences Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Ing Partners Inc - Ing American Century Large Company Value Portfolio | Large-Cap Value | | Sold All | -6,200 | -100 % | | | | - % | | | | | | | News Article | History of Ing Partners Inc - Ing American Century Large Company Value Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Ing Variable Portfolios Inc - Ing International Index Portfolio | No Data | 15,050 | New Holding | 15,050 | 100 % | | $316,351 | | - % | | | | | | | News Article | History of Ing Variable Portfolios Inc - Ing International Index Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Ing Variable Portfolios Inc - Ing Vp Index Plus Midcap Portfolio | Mid-Cap Core | 128,801 | Sold Some | -19,999 | -13.44 % | | $2,707,397 | | - % | | | | | | | News Article | History of Ing Variable Portfolios Inc - Ing Vp Index Plus Midcap Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Ing Vp Balanced Portfolio Inc - Ing Vp Balanced Portfolio | Flexible Portfolio | | Sold All | -14,400 | -100 % | | | | - % | | | | | | | News Article | History of Ing Vp Balanced Portfolio Inc - Ing Vp Balanced Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Jnl Variable Fund Llc - Jnlmcm 25 Fund | Specialty & Misc | 36 | Added More | 4 | 12.50 % | | $757 | | - % | | | | | | | News Article | History of Jnl Variable Fund Llc - Jnlmcm 25 Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund | Health/Biotech | 11 | Added More | 1 | 10.00 % | | $231 | | - % | | | | | | | News Article | History of Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Jnl Variable Fund Llc - Jnlmcm Jnl 5 Fund | Specialty & Misc | 27 | No Change | 0 | 0 % | | $568 | | - % | | | | | | | News Article | History of Jnl Variable Fund Llc - Jnlmcm Jnl 5 Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Jnl Variable Fund Llc - Jnlmcm Vip Fund | Specialty & Misc | 15 | No Change | 0 | 0 % | | $315 | | - % | | | | | | | News Article | History of Jnl Variable Fund Llc - Jnlmcm Vip Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mainstay Vp Series Fund Inc - Vp Common Stock Portfolio | Specialty & Misc | | Sold All | -25,283 | -100 % | | | | - % | | | | | | | News Article | History of Mainstay Vp Series Fund Inc - Vp Common Stock Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mainstay Vp Series Fund Inc - Vp Mid Cap Core Portfolio | Mid-Cap Core | | Sold All | -19,605 | -100 % | | | | - % | | | | | | | News Article | History of Mainstay Vp Series Fund Inc - Vp Mid Cap Core Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Northwestern Mutual Series Fund Inc - Index 400 Stock Portfolio | No Data | | Sold All | -50,700 | -100 % | | | | - % | | | | | | | News Article | History of Northwestern Mutual Series Fund Inc - Index 400 Stock Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Ohio National Fund Inc - Equity Portfolio | Specialty & Misc | | Sold All | -2,800 | -100 % | | | | - % | | | | | | | News Article | History of Ohio National Fund Inc - Equity Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Large-Cap Growth Index Portfolio | No Data | 279 | No Compare | | | | $5,865 | | - % | | | | | | | News Article | History of Pacific Select Fund - Pd Large-Cap Growth Index Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -5,589 | -100 % | | | | - % | | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Batterymarch Growth And Income Portfolio | Multi-Cap Growth | | Sold All | -2,600 | -100 % | | | | 6.00 % | $-3,094 | | | | | | News Article | History of Met Investors Series Trust - Batterymarch Growth And Income Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Blackrock Large Cap Core Portfolio | Large-Cap Core | | Sold All | -150,000 | -100 % | | | | 6.00 % | $-178,500 | | | | | | News Article | History of Met Investors Series Trust - Blackrock Large Cap Core Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Third Avenue Small Cap Value Portfolio | Small-Cap Value | 732,400 | Added More | 222,050 | 43.50 % | $14,523,492 | $15,395,048 | $871,556 | 6.00 % | $264,240 | | | | | | News Article | History of Met Investors Series Trust - Third Avenue Small Cap Value Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Schwab Capital Trust - Schwab Technology Fund | Science & Tech | | Sold All | -8,465 | -100 % | | | | 6.00 % | $-10,073 | | | | | | News Article | History of Schwab Capital Trust - Schwab Technology Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 4,654,100 | Sold Some | -3,635,064 | -43.85 % | $91,825,393 | $97,829,182 | $6,003,789 | 6.53 % | $-4,689,233 | | | | | | News Article | History of Amvescap Plc Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 1,044,184 | Sold Some | -205,717 | -16.45 % | $20,601,750 | $21,948,748 | $1,346,997 | 6.53 % | $-265,375 | | | | | | News Article | History of Fmr Corp Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Pax World Balanced Fund - Pax World Balanced Fund | Mixed-Asset Target Allocation Growth | 196,900 | Added More | 10,000 | 5.35 % | $3,884,837 | $4,138,838 | $254,001 | 6.53 % | $12,900 | | | | | | News Article | History of Pax World Balanced Fund - Pax World Balanced Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Pax World Balanced Fund - Pax World Growth Fund | Multi-Cap Growth | 45,747 | Added More | 10,000 | 27.97 % | $902,588 | $961,602 | $59,014 | 6.53 % | $12,900 | | | | | | News Article | History of Pax World Balanced Fund - Pax World Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Pax World Balanced Fund - Pax World Small Cap Fund | No Data | 1,400 | No Change | 0 | 0 % | $27,622 | $29,428 | $1,806 | 6.53 % | $0 | | | | | | News Article | History of Pax World Balanced Fund - Pax World Small Cap Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Rs Variable Products Trust - Rs Partners Vip Series | Specialty & Misc | 6,618 | New Holding | 6,618 | 100 % | $130,573 | $139,110 | $8,537 | 6.53 % | $8,537 | | | | | | News Article | History of Rs Variable Products Trust - Rs Partners Vip Series Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Buffalo Funds - Buffalo Science And Technology Fund | Science & Tech | | Sold All | -107,000 | -100 % | | | | 4.52 % | $-97,370 | | | | | | News Article | History of Buffalo Funds - Buffalo Science And Technology Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Eaton Vance Growth Trust - Eaton Vance Growth Fund | Multi-Cap Growth | | Sold All | -9,200 | -100 % | | | | 4.52 % | $-8,372 | | | | | | News Article | History of Eaton Vance Growth Trust - Eaton Vance Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 1,248 | No Change | 0 | 0 % | $25,097 | $26,233 | $1,136 | 4.52 % | $0 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Usaa Mutual Funds Trust - Total Return Strategy Fund | Specialty & Misc | | Sold All | -12,800 | -100 % | | | | 4.52 % | $-11,648 | | | | | | News Article | History of Usaa Mutual Funds Trust - Total Return Strategy Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | 10,000 | New Holding | 10,000 | 100 % | $201,100 | $210,200 | $9,100 | 4.52 % | $9,100 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wasatch Funds Inc - Wasatch Core Growth Fund | Small-Cap Core | 451,515 | Added More | 300,930 | 199.84 % | $9,079,967 | $9,490,845 | $410,879 | 4.52 % | $273,846 | | | | | | News Article | History of Wasatch Funds Inc - Wasatch Core Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wasatch Funds Inc - Wasatch Global Opportunities Fund | No Data | 15,300 | Added More | 7,800 | 104.00 % | $307,683 | $321,606 | $13,923 | 4.52 % | $7,098 | | | | | | News Article | History of Wasatch Funds Inc - Wasatch Global Opportunities Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wasatch Funds Inc - Wasatch Heritage Value Fund | No Data | 2,900 | New Holding | 2,900 | 100 % | $58,319 | $60,958 | $2,639 | 4.52 % | $2,639 | | | | | | News Article | History of Wasatch Funds Inc - Wasatch Heritage Value Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wasatch Funds Inc - Wasatch Small Cap Value Fund | Small-Cap Core | 95,050 | New Holding | 95,050 | 100 % | $1,911,456 | $1,997,951 | $86,496 | 4.52 % | $86,496 | | | | | | News Article | History of Wasatch Funds Inc - Wasatch Small Cap Value Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wisdomtree Trust - Wisdomtree Diefa Fund | Specialty & Misc | 398 | Sold Some | -238 | -37.42 % | $8,004 | $8,366 | $362 | 4.52 % | $-217 | | | | | | News Article | History of Wisdomtree Trust - Wisdomtree Diefa Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wisdomtree Trust - Wisdomtree Midcap Dividend Fund | Mid-Cap Core | 6,884 | Added More | 803 | 13.20 % | $138,437 | $144,702 | $6,264 | 4.52 % | $731 | | | | | | News Article | History of Wisdomtree Trust - Wisdomtree Midcap Dividend Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wisdomtree Trust - Wisdomtree Total Dividend Fund | Specialty & Misc | 37,388 | Added More | 36,579 | 4521.50 % | $751,873 | $785,896 | $34,023 | 4.52 % | $33,287 | | | | | | News Article | History of Wisdomtree Trust - Wisdomtree Total Dividend Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Wisdomtree Trust - Wisdomtree Total Earnings Fund | Specialty & Misc | 157 | Added More | 12 | 8.27 % | $3,157 | $3,300 | $143 | 4.52 % | $11 | | | | | | News Article | History of Wisdomtree Trust - Wisdomtree Total Earnings Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-Q | American Century Capital Portfolios Inc - Small Cap Value Fund | Small-Cap Value | 170,000 | Added More | 110,000 | 183.33 % | $3,435,700 | $3,573,400 | $137,700 | 4.00 % | $89,100 | | | | | | News Article | History of American Century Capital Portfolios Inc - Small Cap Value Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Calvert Social Index Series Inc - Calvert Social Index Fund | Multi-Cap Core | 1,812 | Added More | 127 | 7.53 % | $36,621 | $38,088 | $1,468 | 4.00 % | $103 | | | | | | News Article | History of Calvert Social Index Series Inc - Calvert Social Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Dws Variable Series Ii - Dws Blue Chip Vip | Specialty & Misc | | Sold All | -3,400 | -100 % | | | | 4.00 % | $-2,754 | | | | | | News Article | History of Dws Variable Series Ii - Dws Blue Chip Vip Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Dws Variable Series Ii - Dws Mid Cap Growth Vip | Mid-Cap Growth | 6,900 | Sold Some | -5,500 | -44.35 % | $139,449 | $145,038 | $5,589 | 4.00 % | $-4,455 | | | | | | News Article | History of Dws Variable Series Ii - Dws Mid Cap Growth Vip Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Evergreen Equity Trust De - Evergreen Growth Fund | Multi-Cap Growth | | Sold All | -10,845 | -100 % | | | | 4.00 % | $-8,784 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 1000 Growth Index Fund | Multi-Cap Growth | 214,595 | Sold Some | -1,834 | -0.84 % | $4,336,965 | $4,510,787 | $173,822 | 4.00 % | $-1,486 | | | | | | News Article | History of Ishares Trust - Ishares Russell 1000 Growth Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 1000 Index Fund | Specialty & Misc | 53,414 | Sold Some | -420 | -0.78 % | $1,079,497 | $1,122,762 | $43,265 | 4.00 % | $-340 | | | | | | News Article | History of Ishares Trust - Ishares Russell 1000 Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 6,560 | Sold Some | -524 | -7.39 % | $132,578 | $137,891 | $5,314 | 4.00 % | $-424 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 29,837 | Added More | 1,740 | 6.19 % | $603,006 | $627,174 | $24,168 | 4.00 % | $1,409 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Midcap Growth Index Fund | Mid-Cap Growth | 180,366 | Added More | 20,746 | 12.99 % | $3,645,197 | $3,791,293 | $146,096 | 4.00 % | $16,804 | | | | | | News Article | History of Ishares Trust - Ishares Russell Midcap Growth Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Midcap Index Fund | Mid-Cap Core | 158,063 | Sold Some | -15,993 | -9.18 % | $3,194,453 | $3,322,484 | $128,031 | 4.00 % | $-12,954 | | | | | | News Article | History of Ishares Trust - Ishares Russell Midcap Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Mid Cap Growth Portfolio | Mid-Cap Growth | 2,139 | New Holding | 2,139 | 100 % | $43,229 | $44,962 | $1,733 | 4.00 % | $1,733 | | | | | | News Article | History of Seasons Series Trust - Mid Cap Growth Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Sti Classic Funds - Small Cap Value Equity Fund | Small-Cap Value | 119,300 | Added More | 3,300 | 2.84 % | $2,411,053 | $2,507,686 | $96,633 | 4.00 % | $2,673 | | | | | | News Article | History of Sti Classic Funds - Small Cap Value Equity Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Sunamerica Equity Funds - New Century | Flexible Portfolio | | Sold All | -25,600 | -100 % | | | | 4.00 % | $-20,736 | | | | | | News Article | History of Sunamerica Equity Funds - New Century Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Value Line Asset Allocation Fund Inc - Value Line Asset Allocation Fund Inc | Mixed-Asset Target Allocation Growth | | Sold All | -10,000 | -100 % | | | | 4.00 % | $-8,100 | | | | | | News Article | History of Value Line Asset Allocation Fund Inc - Value Line Asset Allocation Fund Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Value Line Emerging Opportunities Fund Inc - Value Line Emerging Opportunities Fund Inc | Small-Cap Growth | | Sold All | -59,000 | -100 % | | | | 4.00 % | $-47,790 | | | | | | News Article | History of Value Line Emerging Opportunities Fund Inc - Value Line Emerging Opportunities Fund Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 533,643 | Sold Some | -21,558 | -3.88 % | $10,784,925 | $11,217,176 | $432,251 | 4.00 % | $-17,462 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Dws Advisor Funds - Dws Mid Cap Growth Fund | Mid-Cap Growth | 132,500 | Sold Some | -238,900 | -64.32 % | $2,679,150 | $2,785,150 | $106,000 | 3.95 % | $-191,120 | | | | | | News Article | History of Dws Advisor Funds - Dws Mid Cap Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Icon Funds - Icon Healthcare Fund | Health/Biotech | | Sold All | -45,000 | -100 % | | | | 3.95 % | $-36,000 | | | | | | News Article | History of Icon Funds - Icon Healthcare Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Lb Series Fund Inc - Thrivent Partner Socially Responsible Stock Portfolio | No Data | | Sold All | -1,600 | -100 % | | | | 3.95 % | $-1,280 | | | | | | News Article | History of Lb Series Fund Inc - Thrivent Partner Socially Responsible Stock Portfolio Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Mgi Funds - Mgi Us Large Cap Value Equity Fund | Large-Cap Value | 15,300 | New Holding | 15,300 | 100 % | $309,366 | $321,606 | $12,240 | 3.95 % | $12,240 | | | | | | News Article | History of Mgi Funds - Mgi Us Large Cap Value Equity Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2009-06-30 | N-CSR | Sit Mutual Funds Inc - Sit Small Cap Growth Fund | Mid-Cap Growth | | Sold All | -7,100 | -100 % | | | | 3.95 % | $-5,680 | | | | | | News Article | History of Sit Mutual Funds Inc - Sit Small Cap Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tamarack Funds Trust - Tamarack Mid Cap Growth Fund | Mid-Cap Growth | | Sold All | -33,220 | -100 % | | | | 3.95 % | $-26,576 | | | | | | News Article | History of Tamarack Funds Trust - Tamarack Mid Cap Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | | Sold All | -5,378 | -100 % | | | | 3.95 % | $-4,302 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | 8,392 | Sold Some | -4,700 | -35.89 % | $169,686 | $176,400 | $6,714 | 3.95 % | $-3,760 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Van Kampen Life Investment Trust - Van Kampen Life Investment Trust Global Tactical Asset | No Data | 100 | No Compare | | | $2,022 | $2,102 | $80 | 3.95 % | | | | | | | News Article | History of Van Kampen Life Investment Trust - Van Kampen Life Investment Trust Global Tactical Asset Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard 500 Index Fund | S&P 500 Index | | Sold All | -1,166,415 | -100 % | | | | 3.95 % | $-933,132 | | | | | | News Article | History of Vanguard Index Funds - Vanguard 500 Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | | Sold All | -690,686 | -100 % | | | | 3.95 % | $-552,549 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 199,395 | Sold Some | -85,755 | -30.07 % | $4,031,767 | $4,191,283 | $159,516 | 3.95 % | $-68,604 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 982,311 | Added More | 26,284 | 2.74 % | $19,862,328 | $20,648,177 | $785,849 | 3.95 % | $21,027 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Value Index Fund | Large-Cap Value | 76,540 | New Holding | 76,540 | 100 % | $1,547,639 | $1,608,871 | $61,232 | 3.95 % | $61,232 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Value Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 40,798 | New Holding | 40,798 | 100 % | $824,936 | $857,574 | $32,638 | 3.95 % | $32,638 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 50,178 | New Holding | 50,178 | 100 % | $1,014,599 | $1,054,742 | $40,142 | 3.95 % | $40,142 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-26 | 2009-06-30 | N-CSRS | M Fund Inc - Frontier Capital Appreciation Fund | Specialty & Misc | | Sold All | -41,300 | -100 % | | | | 3.39 % | $-28,497 | | | | | | News Article | History of M Fund Inc - Frontier Capital Appreciation Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-26 | 2009-06-30 | N-Q | Vanguard Morgan Growth Fund - Vanguard Morgan Growth Fund | Multi-Cap Growth | 233,840 | New Holding | 233,840 | 100 % | $4,753,967 | $4,915,317 | $161,350 | 3.39 % | $161,350 | | | | | | News Article | History of Vanguard Morgan Growth Fund - Vanguard Morgan Growth Fund Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-25 | 2009-06-30 | 13F-HR/A | Jefferies Group Inc | Institution | | Sold All | -12,370 | -100 % | | | | 3.54 % | $-8,906 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-24 | 2009-06-30 | 13F-HR | Bank Of Albuquerque Na | No Data | 9,920 | No Compare | | | $201,376 | $208,518 | $7,142 | 3.54 % | | | | | | | News Article | History of Bank Of Albuquerque Na Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-24 | 2009-06-30 | 13F-HR/A | Bank Of Oklahoma National Association | No Data | 32,518 | No Compare | | | $660,115 | $683,528 | $23,413 | 3.54 % | | | | | | | News Article | History of Bank Of Oklahoma National Association Ownership Of Pharmaceutical Product Development Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Franklin Templeton Variable Insurance Products Trust - Franklin Small Cap Value Securities Fund | Small-Cap Value | 520,700 | New Holding | 520,700 | 100 % | $10,570,210 | $10,945,114 | $374,904 | 3.54 % | $374,904 | | | | | | News Article | History of Franklin Templeton Variable Insurance Products Trust - Franklin Small Cap Value Securities Fund Ownership Of Pharmaceutical Product Development Inc |
RSS feed for PPDI